ReportWire

Tag: heart health

  • The Truth About Heart Stents | NutritionFacts.org

    The Truth About Heart Stents | NutritionFacts.org

    [ad_1]

    Coronary artery disease, the number one killer of men and women, involves blockages in the blood vessels that supply the heart muscle. As discussed in my video Do Angioplasty Heart Stent Procedures Work?, low blood flow can lead to a type of chest pain called angina or, if severe enough, a heart attack. Plant-based diets and lifestyle programs have been shown to help reverse these blockages by treating the cause of why our arteries are clogging up in the first place. But, for those unable or unwilling to change their diets, there are drugs that may help, as well as more invasive surgical treatments.

    What Is a Heart Stent?

    You may have heard of open-heart surgery, performed to try to bypass the blockage, or percutaneous coronary intervention. As discussed in my video Why Angioplasty Heart Stents Don’t Work Better, historically, the more common procedure was angioplasty, wherein a tiny balloon is inserted into a narrowed coronary artery feeding your heart to force it to open wider to improve blood flow. Then, stents came into vogue. Instead of just ballooning up the artery, how about permanently inserting a metal mesh tube to prop open the artery? Stents are typically inserted in the groin and threaded all the way up into the heart, and, while stents used to be mostly bare metal, there are now fancy new drug-eluting stents that not only force open arteries, but they also slowly release pharmaceuticals.

    How Serious Is Having a Stent Put In?

    The surgical procedure carries risks—including death. In an emergency setting, while you’re actively having a heart attack, angioplasty can be lifesaving, but hundreds of thousands of these procedures are for stable coronary artery disease, for which there appears to be little or no benefits. As discussed in my video The Risks of Heart Stents, doctors appear to be killing or stroking out thousands of people a year for nothing, and that isn’t even counting the tens of thousands of silent mini-strokes caused by these procedures that may contribute to cognitive decline. Indeed, 11 to 17 percent of people who go through angioplasty or stenting come away with new brain lesions—up to one in six patients.

    Do Stents Work?

    Angioplasty and stents for non-emergency coronary artery disease are among the most common invasive procedures performed in the United States. Millions of people have gotten stents for stable coronary artery disease, yet it now appears that for such patients, angioplasty and stent placement do not actually prevent heart attacks, do not offer long-term angina pain relief, and do not improve survival. Why? Because the most dangerous plaques—the ones most vulnerable to rupture leading to a heart attack—are not the ones doctors put stents into. They often aren’t the ones that are even seen on angiogram to be obstructing blood flow.

    Indeed, in 2007, we learned from the COURAGE trial that angioplasty and stents don’t reduce the risk of death or heart attack, but patients didn’t seem to get the memo. As discussed in my video Why Are Stents Still Used If They Don’t Work?, only 1 percent realize there was no mortality or heart attack benefit, perhaps because most cardiologists failed to happen to mention that fact. One can imagine that if patients actually understood all they were getting was symptomatic relief, they’d be less likely to go under the knife. Ten years later, the ORBITA trial was published, showing even the promise of symptom relief was an illusion.

    Are Stents Really Necessary?

    The implications are profound and far-reaching. First and foremost, the results showed unequivocally that there are no benefits to non-emergency angioplasty and stents for stable heart disease. Basically, patients would be risking harm for no benefit whatsoever, so it’s hard to imagine a scenario where a fully-informed patient would choose an invasive procedure for nothing.

    Yet angioplasty and stent placement continue to be frequently performed for patients with non-emergency coronary artery disease, despite clear evidence that it provides minimal benefit, as discussed in my video Angioplasty Heart Stent Risks vs. Benefits. For example, it does not prevent heart attacks or death, yet as many as nine out of ten patients mistakenly believed that the procedure would reduce their chances of having a heart attack.

    What Are the Side Effects of Heart Stents?

    Stent placement and the blood-thinner drugs you have to go on after the surgery can cause complications, including heart failure, stroke, and death. The risks are relatively low; there’s less than a 1 percent chance it will kill you or stroke you out. The 15 percent risk of heart attack is only if your stent clogs at a later date, which only happens about 1 percent of the time in the near-term. There is a 13 percent risk of kidney injury, due to the dyes that must be injected, but that typically heals on its own. The most serious complications—including death—only happen in about 1 in 150 cases. However, you have to multiply that by the fact that hundreds of thousands of these procedures are performed every year.

    And, again, although stents appeared to offer immediate relief of angina chest pain in stable patients with coronary artery disease, they do not offer long-term angina pain relief and they didn’t actually translate into lower risk of heart attack or death. More on this in my video Do Heart Stent Procedures Work for Angina Chest Pain?.

    Diet After Heart Attack and Stents

    Should we be surprised that angioplasty and stents fail to improve prognosis? After all, neither does anything to modify the underlying disease process itself. In other words, they don’t treat the cause. As discussed in my video Heart Stents and Upcoding: How Cardiologists Game the System, even if stents helped with symptoms beyond the placebo effect, they would still just be treating the symptoms, not the disease, so it’s no wonder the disease continues to progress until the patient is disabled into death.

    Thankfully, we are on the cusp of a seismic revolution in health: not another pill, procedure, or operation, but, instead, treating the underlying cause of heart disease with whole food, plant-based nutrition, the mightiest tool medicine has ever had in its toolbox.

    Heart-Healthy Eating

    The most likely reason the majority of our loved ones will die is heart disease. Atherosclerosis, or hardening of the arteries, begins in childhood, as discussed in my video How Not to Die from Heart Disease. The arteries of nearly all kids raised on the standard American diet already have fatty streaks marking the first stage of the disease—by the time they are ten years old. After that, the plaques start forming in our 20s, get worse in our 30s, and can then start killing us off. In our heart, it’s called a heart attack; in our brain, it can manifest as a stroke. So, for anyone reading this who is older than ten, the choice isn’t whether or not to eat healthfully to prevent heart disease—it’s whether or not you want to reverse the heart disease you likely already have.

    Is that even possible? When researchers took people with heart disease and put them on the kind of plant-based diet followed by populations who did not get epidemic heart disease, their hope was that it might slow down the disease process or maybe even stop it. Instead, something miraculous happened. The disease actually started to reverse. It started to get better. As soon as patients stopped eating artery-clogging diets, their bodies were able to start dissolving away some of the plaque, opening up arteries without drugs and without surgery, suggesting their bodies wanted to heal all along, but just were never given the chance. That improvement in blood flow to the heart muscle itself was after just three weeks of eating healthfully.

    Plant-based diets aren’t just safer and cheaper. They can work better because they let us treat the actual cause of the disease.

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • How to Talk to Your Family About Their Heart Health History

    How to Talk to Your Family About Their Heart Health History

    [ad_1]

    Hypertrophic obstructive cardiomyopathy (HOCM) is the most common genetic heart disease, affecting about 1 in every 500 people, according to the American Heart Association (AHA). In people with HOCM, genetic variants cause the heart’s walls to thicken and stiffen, blocking blood from flowing freely from the left ventricle to the aorta. This, in turn, results in shortness of breath and chest pain (especially during physical activity), abnormal heart rhythms, lightheadedness, dizziness, and fainting, and can worsen over time.

    If a parent has HOCM, offspring have a 50% chance of inheriting it. That means knowing your family’s heart health history is crucial: If your doctor is aware that you have relatives with HOCM, they can “screen family members early on, before they get sick or have any cardiac complications” using EKG and echocardiogram, says Dr. Ali Nsair, co-director of the Hypertrophic Cardiomyopathy Clinic at UCLA Health.

    About 60% of the time, genetic testing can identify a specific change in a gene that causes HOCM. Even if you (or your kids) test negative for the particular genetic variant your parent with HOCM has, you can still be screened every few years with EKGs, echocardiograms, and visits to a cardiologist to make sure complications haven’t popped up, Nsair says.

    And it’s not only HOCM that can cluster in families. “A lot of what ails us is in some sense heritable,” says Dr. Daniele Massera, associate director of the Hypertrophic Cardiomyopathy Program at NYU Langone Health. “Whatever affects your family members might directly affect you.” Other heart conditions, like familial hypercholesterolemia (high cholesterol) and high lipoprotein (a) (proteins and fats that carry cholesterol), can be inherited, and a family history of heart disease that isn’t genetic puts you at higher risk, too.

    But no single risk factor—including genetics—is a guarantee that heart disease will develop down the line: “For me, the most important reason to know your family history is prevention,” says Dr. Svati Shah, a member of the American Heart Association’s National Board of Directors and director of the Duke Adult Cardiovascular Genetics Clinic. If you know you have an increased risk for heart disease due to your genes or family history, which you can’t control, you can take heart-healthy steps to improve the lifestyle factors you can control, such as getting plenty of sleep, eating a balanced diet, and staying active, according to the AHA.

    To make sure you get access to the testing, treatment, and information on lifestyle changes that can help you avoid or delay inherited heart health complications, it’s important to stay on top of your family’s medical history. Here’s how to have those conversations with honesty and compassion while still getting the potentially life-saving answers you need.

    Read More: What It Means if You Have Borderline High Cholesterol—And What to Do About It

    Start with broad questions

    You might open the conversation with a question as simple as “Do you have any kind of heart disease?” or as general as: “Have you ever had any chest pain?” Shah suggests.

    If your relative isn’t entirely sure about their diagnosis or past procedures, consider asking if a doctor has ever told them they had any of the following, according to the Centers for Disease Control and Prevention (CDC):

    • Coronary artery disease or atherosclerosis
    • Heart attack
    • Arrhythmia
    • Atrial fibrillation
    • Cardiomyopathy
    • Heart failure
    • Aortic aneurysm
    • Stroke

    Also ask if they have a pacemaker or have ever had heart bypass surgery. If they’ve given birth, Shah suggests adding: “Did anything happen [to your heart] when you had your babies? Did you get really high blood pressure?” And whenever possible, ask what age they were when they experienced these conditions or complications for the first time, according to the CDC.

    The details might get fuzzier as you go back generations. “Often people say [things like], ‘My dad died at 47 from a heart attack,’ but it’s actually that they didn’t wake up from sleep, and it may not have been a heart attack,” Massera says.

    Try to get as many details as you can, because those specifics can help your doctor determine the best next steps for you. For example, you might need different testing if your 47-year-old father died of sudden cardiac arrest (when the heart suddenly stops beating) rather than a heart attack (when an artery to the heart is blocked). “To distinguish between the two is really critical: A heart attack is common, but if we identify sudden cardiac death as the real mechanism, then we’re homing in on a more narrow group of conditions that will require testing that you wouldn’t necessarily do if you’re talking about a heart attack,” Massera says.

    While heart attacks, strokes, and sudden cardiac death might stand out the most in your relatives’ memories, make sure to ask about heart disease risk factors too, like high blood pressure, high cholesterol, and diabetes. “There is a strong predictor among those factors that can lead to heart disease and heart failure,” Massera says.

    Talk to three generations on both sides of your family

    Ideally, aim to include three generations on both sides of your family in your discussions about heart health: your grandparents, your parents and their siblings, and your siblings.

    “Backwards more than three generations, people don’t really know what happened to those relatives,” Shah says. But any information you can collect is still better than nothing, especially if you continue to gather knowledge over time. “[Learn] as much as you can, and it can be over the course of many years that you fill in the details,” she says.

    If you or your siblings have children, note any known heart health information about them, too, per the CDC.

    Be gentle

    These discussions may not go as well if your brother feels interrogated or your mother feels blamed. “These can be really laden conversations,” Shah says. “Especially when you start talking about weight, high cholesterol, blood pressure—people can get sensitive about that.”

    If a family member remains standoffish, don’t press: “If that person isn’t ready, it’s OK, circle back to it,” Shah says. Your relatives might feel more comfortable in a group setting. “Sometimes one on one, people ask: ‘Why are you calling me? Why are you worried about my health? Why aren’t you worried about other people’s health?’” Group conversations have the added benefit of helping to nudge everyone’s memory in the right direction, too. “Sometimes one person remembers one thing, another person remembers another thing, but if you spoke with each one independently, you wouldn’t have made the connection,” Shah says.

    These conversations don’t have to be done in person, but face-to-face discussions allow you to pick up on a relative’s body language more easily and change the subject if you can tell they’re uncomfortable.

    Record the information somewhere you can access it easily

    You can use digital tools like the Surgeon General’s My Family Health Portrait or the Global Alliance for Genomics and Health’s Family History Toolkit to record and store your family’s heart health history.

    Don’t feel pressured to use software: Typing notes into your smartphone or jotting them down on paper is fine, too. As long as it’s a system that works for you and you know where the information is, you’ll be less likely to forget any details when you’re actually sitting in front of your doctor.

    “I love it when patients come in with a printout,” Massera says. He makes sure to devote plenty of time to walk through all of a patient’s relatives and their relevant health history, but recognizes a typical primary care doctor might not have that luxury. “You can’t do this if you see a patient in five minutes,” he says. If you feel like your doctor isn’t giving you enough time to cover your family history thoroughly, it’s OK to ask for a longer appointment to address your concerns, he adds.

    Read MoreHow Stress Affects Your Heart Health

    Report back to your doctor

    Simply knowing your family’s heart health history isn’t enough to prevent your own heart issues. Sharing what you’ve learned with your doctor is key to determining the screenings, treatment, or lifestyle changes that might benefit you.

    To that end, share “broadly” with your primary care doctor once you’ve asked your family about their heart health, Nsair says. Your doctor will dig deeper into the information that’s most relevant to your individual health, but it’s always better to provide too much than too little.

    A history of heart failure, heart rhythm disorders, stroke, and sudden death, especially in relatives younger than 40 or 50, will likely prompt your primary care doctor to refer you to a cardiologist. That person or your primary care doctor can help you identify modifiable risk factors that you can change, such as quitting smoking, adopting a balanced diet, starting an exercise routine, and maintaining a healthy weight.

    You won’t have to do this every time you visit the doctor: Once you’ve shared your family heart health history, that information is entered into your medical records, so anyone who is a part of your care team will have access to the same details.

    Chat again whenever big changes occur

    Your family’s heart health will continue to change over time—after all, many heart issues, including HOCM, are more common in middle age—so it’s hard to say exactly how often to ask your relatives about their heart health.

    In general, it’s a good idea to collect more information whenever a family member experiences a major heart-related health issue, like a sudden death, cardiac arrest, or having a defibrillator implanted. “This is not a conversation you need to have every year. But every few years, reassess,” Shah advises.

    Remember, these conversations may be challenging, but they’re empowering you with the information you need to live well for longer. “Genetics is not destiny. There’s a saying that genetics loads the gun, but the environment pulls the trigger,” Shah says. “You have control over this.”

    [ad_2]

    Sarah Klein

    Source link

  • Why Heart Disease Research Still Favors Men

    Why Heart Disease Research Still Favors Men

    [ad_1]

    Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.

    Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.

    She knew she was having a heart attack.

    What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to stop the buildup of plaque in her arteries that caused the heart attack and two others that followed.

    Fitzgerald’s case illustrates a dangerous gap in medical care between men and women. While they are equally likely to suffer heart attacks, women are more likely to die from theirs. It’s one of the many symptoms of the medical system’s neglect of women.

    Life-saving statins, like so many other medications, have been developed based on clinical trials that primarily recruited men. As a result, many women like Fitzgerald don’t receive prescriptions for the drugs that could help them the most, says Dr. Laxmi Mehta, director of Preventative Cardiology and Women’s Cardiovascular Health at The Ohio State University.

    “There were a lot of trials. But women weren’t included as much,” says Mehta, who serves on the American Heart Association’s Research Goes Red Science Advisory Group. When women need treatment for heart conditions, she says, “we are assuming we are providing the best care based on data from men.”

    Read More: What It Means if You Have Borderline High Cholesterol—And What to Do About It

    More than 30 years ago, Congress directed the National Institutes of Health to include as many women as men in clinical trials. But while some progress has been made, equity remains elusive. And that’s dangerous for women. “Since 2000, women in the United States have reported total adverse events from approved medicines 52% more frequently than men, and serious or fatal events 36% more frequently,” research firm McKinsey & Company said in a report released in January.

    Now, the Biden administration is taking a run at it.

    Last year, the administration established a White House Initiative on Women’s Health Research and, in February, it announced it would be dedicating $100 million to the newly formed Advanced Research Projects Agency for Health (ARPA-H) to spearhead efforts to increase early stage research focusing on women.

    “For far too long, scientific and biomedical research excluded women and undervalued the study of women’s health. The resulting research gaps mean that we know far too little about women’s health across women’s lifespans, and those gaps are even more prominent for women of color, older women, and women with disabilities,” Biden said in an executive order signed in March.

    Heart disease should be a bright spot in this black hole of medical research. It was the recognition in the 1980s that heart disease was killing women at similar rates to men that kickstarted passage of the 1993 law requiring equity in clinical trials. The American Heart Association has spent decades funding research and leading awareness campaigns about women’s risks.

    But gaps persist, says Dr. Martha Gulati, president of the American Society for Preventive Cardiology and a cardiologist at Cedars-Sinai Hospital in Los Angeles. “We don’t get represented in trials,” Gulati told a seminar sponsored by the Society for Women’s Health Research in February.

    Read More: Why Are So Many Young People Getting Cancer?

    One example: Dr. Safi Khan of West Virginia University and colleagues reviewed 60 trials of cholesterol-lowering drugs conducted between 1990 and 2018. Not even a third of the people enrolled—28.5%—were women, they reported in JAMA Network Open in 2020. The trials’ findings likely did not accurately represent the public as a whole, they say.

    “Medical research is several steps behind on women and heart disease, and that is a major contributor to ongoing ignorance about the problem on the part of both the public and a range of medical professionals,” says Dr. Harmony Reynolds, a cardiologist at NYU Langone Health. “Everywhere along the way, there is different treatment for women, and there is some bias there.”

    Statins have been widely described as wonder drugs, lowering the risk of major heart events such as heart attack or stroke by about 25%. Women are less likely than men to be offered these drugs. And when they do take them, women are more likely to stop using them because of perceived side effects. But no major study digs into the actual rate of side effects among females, or what might lie behind such differences.

    Further studies might uncover additional benefits, says Dr. JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. There are hints that statins might lower a woman’s risk of dying from cancer, including ovarian cancer.

    Failure of recognition

    Fitzgerald was 60, had higher-than-optimal blood pressure, unhealthy cholesterol levels, and a family history of heart disease, says Reynolds, Fitzgerald’s new cardiologist. “Katherine had multiple risk factors. Many of my patients are told their blood pressure and cholesterol are ‘borderline’ when really they should be treated,” she says.

    Doctors often blame women for failing to recognize their own heart disease symptoms, but the evidence shows medical professionals miss them, too. 

    The symptoms of heart attacks in men are widely known: crushing chest pain, a telling sensation in the left arm, or sudden collapse. Women, on the other hand, often feel nausea, jaw pain, or lightheadedness,

    Fitzgerald did recognize her symptoms. At the party where she suffered her first heart attack, she begged for an ambulance. But other guests, including a physician friend, said they didn’t think she needed medical attention.

    When paramedics finally arrived, they, too, dismissed her fears and diagnosed a panic attack. They sent her home. “If I had been a man, there is no way the paramedic wouldn’t have taken me to the hospital and I wouldn’t be in the mess I am now,” Fitzgerald says.

    Fitzgerald waited two days to visit an emergency room. By then, some of her heart muscle had died. She received two stents to hold open clogged arteries, but suffered two more heart attacks in the following months. She now stays out of the courtroom and sticks to less-stressful desk work.

    “I take care of all these young women with heart attacks and I hear so many stories about people saying they were ignored,” says Reynolds.

    Waiting for attention

    The problem is not just anecdotal. Reynolds and colleagues studied the problem by looking at more than 29 million emergency room visits by people under 55 reporting chest pain. 

    “In that study we show young women coming in with chest pains and they are waiting longer to be seen,” Reynolds says. “The women are waiting too long and women of color were waiting even longer. So we know there is some subtle bias there.”

    Read More: What the Science Says About the Health Benefits of Vitamins and Supplements

    Doctors can use risk calculators to try to forecast a patient’s future likelihood of heart disease and treat accordingly. But Dr. Stephanie Faubion, medical director of the Menopause Society, says they do not work well for women.

    “That is because we are still using those that were developed and made for men,” says Faubion, who is also director of the Mayo Clinic Center for Women’s Health in Jacksonville, Florida.

    Women have many specific heart risks. They have smaller coronary arteries, thinner heart walls, and suffer more heart damage from diabetes. Pregnancy can raise risks in various ways. Autoimmune diseases such as rheumatoid arthritis also add heart disease risks, and women are far more likely than men to have these conditions. 

    Women who start menstruation early, or who reach menopause early, have higher heart disease rates. Birth control pills can raise the risk for blood clots, strokes, and heart attacks.

    Perhaps the most recent instance of women being left out of heart disease research can be seen in the trials of highly popular diabetes drugs such as semaglutide, sold under the brand names Ozempic and Wegovy.

    The drugs cause dramatic weight loss, which made researchers wonder if they might lower heart disease rates, too. They do, according to several studies, and the U.S. Food and Drug Administration now approves their use to prevent heart disease.

    But none of the weight-loss trials, published in prestigious medical journals such as the New England Journal of Medicine and the Journal of the American Medical Association, break out separate data on men and women. And while the weight-loss studies did include far more women than men, many of the follow-on heart disease trials did not.

    “They report the sex. They report ‘we have this many men, this many women,’” says Faubion. “They didn’t disaggregate the data on sex so they don’t know if it works better, the same, or worse in women than it did in men.”

    Left out

    Dr. Robert Kushner, a professor of medicine at Northwestern University who led some of the weight-loss studies, says he was surprised at the discrepancy between the enrollment of women in the obesity trials of semaglutide—in which about three-quarters of volunteers were women—and in the heart disease trials, in which women represented fewer than 28% of participants.

    He says researchers recruited people already being treated for heart disease. “Predominantly, the ones who are getting care and being seen around the world were men,” Kushner says.

    Kushner says he has yet to analyze results in his trial of semaglutide and weight loss by sex.

    Missing out on breakthroughs

    Harvard Medical School’s Manson has been sounding the alarm on discrepancies in medical research for decades.

    “Raising more questions is what leads to the major breakthroughs,” she says.

    Yet she has been mostly ignored, even though she helped lead the largest-ever study looking specifically at women’s health—the Women’s Health Initiative, which involved more than 160,000 women over 15 years.

    The study was initially designed to see if hormone therapy in women past menopause could reduce their rising rates of heart disease and breast cancer. It also later looked for evidence of effects on bone strength, other cancers, dementia and quality of life.

    The first results were startling. The hormone therapy used in the trial raised the risk of breast cancer and failed to reduce heart disease.

    Read More: Menopause Is Finally Going Mainstream

    “Many clinicians stopped prescribing hormone therapy altogether. Many women tossed their pills and patches,” Manson says. When the trial started, an estimated 40% of menopausal women used hormone therapy. Now, Manson estimates, only about 4% do.

    The study has since been shown to have been flawed. The average age of the women in the study was 63—well past menopause. And the hormone therapy used was a high-dose hormone distilled from horse estrogens.

    Later studies have indicated that lower doses and different formulations such as patches, given to women as they start menopause, may be much less harmful while reducing hot flashes, sleep loss and other symptoms. “These formulations don’t go to the liver and should be safer,” Manson says. There’s also tantalizing evidence they may lower the risk of heart disease.

    Meanwhile, the lack of data means that many women who would benefit from hormone therapy are not getting it, says Faubion. 

    Back in 1993, it took the considerable efforts of Dr. Bernadine Healy, the first female director of the NIH, to persuade Congress to directly fund medical research on women and heart disease.

    “They are just not going to do that again. It’s too expensive,” says Faubion.

    Biden asked Congress for $12 billion to improve research planning and to set up a network of research centers to focus on women’s health. And NIH has encouraged requests for money to study women in particular.

    But when Congress passed a last-minute spending bill in March, it kept health funding flat. The Republican-led House did not address Biden’s request or allocate any cash for additional research into women’s health.

    Sign up for the Fuller Project’s newsletter, and follow the organization on X or LinkedIn.

    [ad_2]

    Maggie Fox

    Source link

  • How Hypertrophic Cardiomyopathy Progresses in Adults

    How Hypertrophic Cardiomyopathy Progresses in Adults

    [ad_1]

    Hypertrophic cardiomyopathy is the most common form of genetic heart disease worldwide. Researchers have estimated that up to 1 in 200 people have the condition, which is characterized by an abnormal thickening of the walls of the heart. This thickening can make it difficult for the heart to pump blood.

    Hypertrophic cardiomyopathy can be a deadly disease, and there was a time when it was largely untreatable. But the last 20 years have witnessed a sea change in the condition’s management—a change that has led to an estimated 10-fold decrease in deaths.

    “Hypertrophic cardiomyopathy has this reputation that it’s difficult to live with, and that the outlook is grim,” says Dr. Barry Maron, a cardiologist and hypertrophic cardiomyopathy specialist at Beth Israel Lahey Health in Burlington, Mass. “That used to be true, but there have been huge advances in clinical care and clinical research, and hypertrophic cardiomyopathy is now characterized very differently.”

    “The reality,” he adds, “is that very few people die of the disease, and fully half of patients belong in a group we consider benign and stable.”

    Here, Maron and other experts describe what it’s like to live with hypertrophic cardiomyopathy. They explain the different stages or forms of the disease, how and why it progresses, and how treatment may evolve over time. They also talk about the outlook for people who are diagnosed with the condition.

    An unpredictable disease

    Some medical conditions—certain forms of cancer, for example—are characterized by different stages. Those stages help determine treatment, and they also reflect a patient’s prognosis.

    Experts say hypertrophic cardiomyopathy is different; it doesn’t play by such tidy rules. “It’s an incredibly heterogeneous disease, and the more we learn about it, the more complex it gets,” says Dr. Christopher Kramer, distinguished professor and chief of cardiovascular medicine at the University of Virginia School of Medicine. The condition can affect the physical properties of the heart in different ways, he says, and trying to anticipate how it will behave over time is difficult. “To say to a patient, ‘You’re going to do this, and this is your likely outcome’—that’s fraught,” he adds.

    Maron agrees that “there is no average” when it comes to hypertrophic cardiomyopathy. However, he says that the disease can be broken down into four general pathways. “The first pathway is the benign and stable course, and thankfully this is the most common of the four,” he says. These are patients whose disease tends to be caught incidentally sometime in midlife; for example, they undergo some type of medical imaging and their doctor notices an irregularity in their heart function—a heart murmur, for example. This leads to follow-up testing that reveals hypertrophic cardiomyopathy. In these cases, a person’s myopathy may not be obstructive, meaning it’s not limiting blood flow, and it may require little more than follow-up monitoring to ensure it’s not getting worse.

    “The second pathway involves heart failure due to some kind of obstruction,” Maron says. In these obstructive cases, a person’s cardiomyopathy restricts the flow of blood out of the heart. These patients often have symptoms such as chest pain or shortness of breath. Symptoms can range from severe to very mild—so mild that a person may live with them for years without thinking much of them. “Patients will say they have no symptoms, but once you start asking questions, you find they’ve never been able to keep up with friends during exercise, or they’re often short of breath,” says Dr. Milind Desai, a cardiologist and hypertrophic cardiomyopathy specialist at the Cleveland Clinic. “A lot of people don’t realize how they’ve adapted their lifestyles to the condition over the years.”

    Fortunately, this obstruction-related heart failure is often reversible with the help of either medication or some type of procedure, such as surgery to remove part of the thickened heart muscle. In rare and severe cases, a person’s myopathy may not respond to these treatments; or they may respond well initially, but then the condition eventually grows worse. “A small subset of patients develop advanced hypertrophic cardiomyopathy where the muscle of the heart is thick and stiff and non-complaint, and the only option might be a heart transplant,” Desai says. “But that, mercifully, is only the case in 3% to 5% of patients.”

    The third pathway involves people whose hypertrophic cardiomyopathy leads to atrial fibrillation—a condition where the rhythms of the upper and lower chambers of the heart are misaligned. Atrial fibrillation can lead to a stroke if left untreated, and many of these patients will require anticoagulant drugs (such as blood thinners), and perhaps medication or surgery.

    “The fourth pathway is someone who is at risk for sudden cardiac death,” Maron says. While identifying these cases still involves some educated guesswork, he says the latest diagnostic tools are very good at identifying at-risk patients. Treatment typically involves implanting a small defibrillator, or ICD, to correct irregular heart rhythms. “Implantable defibrillators have saved countless lives,” he adds.

    While these four pathways can help sort people with hypertrophic cardiomyopathy into four rough groups, experts reiterate that the course of the disease is hard to anticipate. However, with proper care, they also say that most people diagnosed with hypertrophic cardiomyopathy will not die of the disease. “At this point, most well-managed patients can expect to live a normal lifespan,” Desai says.

    Read More: What to Know About Hypertrophic Cardiomyopathy in Kids

    How and why the condition progresses

    Here again, experts stress the unpredictability of the disease. “Progression of hypertrophic cardiomyopathy is highly variable,” Kramer says. “It may progress and it may not, and we’re doing studies to understand who is most likely to progress and why.”

    People with genetic forms of the condition—meaning those who have inherited one or more of the genetic mutations associated with hypertrophic cardiomyopathy—may have more severe and aggressive disease that often manifests earlier in life. But this isn’t always the case. “There is a portion of patients who have a genetic mutation but never develop the overt disease, and we’d never know they had it if we didn’t look for it,” says Desai. However, among patients with obstructive forms of hypertrophic cardiomyopathy—either with or without symptoms—experts say the condition is likely to get worse if left untreated. The muscle thickening will advance, symptoms will develop or become more severe, and the risk of a person developing atrial fibrillation or other life-threatening complications will increase, he says.

    While predicting the course of the disease can be difficult, experts say that people who are symptomatic and diagnosed with the condition at a young age tend to face more challenges than people who are older at the time of diagnosis. “If you’re diagnosed at age 50 or 60, your prognosis is usually good—probably similar to age-matched controls,” Kramer says. “But if you have a family history of the disease and you’re diagnosed at 25, that’s less optimal.”

    Other health issues can also advance the disease. Experts say obesity, high blood pressure, and diabetes can make underlying hypertrophic cardiomyopathy worse. “It’s important to stay on the ball with your health,” Desai says.

    How treatment may evolve

    At the time of diagnosis, most people with hypertrophic cardiomyopathy will have no symptoms and no evidence of an obstruction. Apart from follow-up monitoring, most won’t require treatment.

    If the disease progresses—meaning, an obstruction or other threat to the heart arises—treatment may involve an implantable defibrillator, or medications intended to manage symptoms or reduce the risks of complications. For example, the latest anticoagulant drugs have “come close to obliterating” the risk of stroke in people who develop atrial fibrillation as a result of hypertrophic cardiomyopathy, Maron says. Meanwhile, a newer drug called mavacamten can help reduce symptoms, and possibly even reverse some heart-muscle thickening, in people with obstructive forms of the disease. Experts say this drug has helped improve quality of life for many patients, but it’s not a cure-all. “Mavacamten has made a beneficial contribution, but so far there’s nothing about this class of drug that will have a direct effect on mortality,” Maron says.

    If a person responds well to the drug, they must stay on it indefinitely and undergo quarterly monitoring to ensure the heart’s functioning is stable. If their heart’s condition worsens or symptoms persist, experts say the next step in treatment is likely to be some kind of procedure. For patients who are younger or those experiencing severe obstruction, doctors may recommend a septal myectomy—an open-heart surgery to remove the thickened muscle. “This surgery is a one-time thing,” Maron says. Research has found that greater than 90% of people who undergo this surgery have significant improvement of symptoms and enjoy a long-term survival benefit. However, the procedure can be risky if not performed at a top medical institution. In patients for whom open-heart is too dangerous, such as among older seniors, experts may recommend a procedure called an alcohol septal ablation. This involves injecting a small amount of alcohol into the heart, which can shrink the thickened muscle and improve blood flow.

    For “a very small number of patients”—and for reasons that are not well understood—Maron says the condition will continue to worsen despite treatment. In these cases, he says a heart transplant may ultimately be necessary.

    A positive outlook

    While some new medications have helped advance the treatment of hypertrophic cardiomyopathy, experts say improvements in their knowledge of the disease and its clinical management deserve most of the credit for reducing mortality. “When I started 40 years ago, mortality was 6% per year, and treatment was inadequate at best,” Maron says. Nowadays, the annual risk of death for a patient is below 1% percent, his research has estimated.

    Experts are also looking ahead to further advancements—and maybe even early interventions that could neutralize the disease before it takes hold. Desai mentions gene editing as, perhaps, the “next frontier” in hypertrophic cardiomyopathy care. “This would involve removing the abnormal piece of genetic material that causes hypertrophic cardiomyopathy,” he says. Gene therapies that aim to replenish certain protein deficiencies are also an area of active research. “If the concept works, in the future patients could walk into the clinic, get an infusion, take immunosuppressants for a few weeks, and potentially be cured or significantly improved,” he says. In the near term, experts are also exploring how the newest medications, if taken early, might be able to reduce or arrest the condition’s progression. “A lot of exciting things are happening in this space,” Desai says.

    Hypertrophic cardiomyopathy remains a shifty and unpredictable foe. But experts say they’ve learned to roll with its punches. “Things have moved in the direction we hoped,” Maron says. “This is now a very treatable disease.”

    [ad_2]

    Markham Heid

    Source link

  • The Pros of Garlic Powder for Heart Disease  | NutritionFacts.org

    The Pros of Garlic Powder for Heart Disease  | NutritionFacts.org

    [ad_1]

    See what a penny a day’s worth of garlic powder can do.

    In ancient Greece, “the Art of Medicine was divided into three parts”: cures through diet, cures through drugs, and cures through surgery. Garlic, Hippocrates wrote, was one such medicinal food, but that was to treat a nonexistent entity called “displacement of the womb,” so ancient wisdom can only go so far.

    Those who eat more than a clove of garlic a day do seem to have better artery function than those who eat less than that, but you don’t know if it’s cause-and-effect until you put it to the test. 

    As I discuss in my video Benefits of Garlic Powder for Heart Disease, heart disease patients were randomized to receive either garlic powder or placebo tablets two times a day for three months. Those lucky enough to be in the garlic group got a significant boost in their artery function—a 50 percent increase in function from taking only 800 mg of garlic powder a day. That’s just a quarter teaspoon of garlic powder. A 50 percent increase in artery function for less than a penny daily!

    If regular, plain old garlic powder can do that, what about those fancy Kyolic® aged garlic extract supplements? They can be 30 times more expensive and don’t work at all. After four weeks, there was zero significant improvement. It’s hard to improve on Mother Nature.

    Garlic powder can improve the function of our arteries, but what about the structure of our arteries? Dozens of studies on garlic all compiled together show that garlic can reduce cholesterol levels in the blood by more than 16 points. So, might garlic powder actually be able to slow the progression of atherosclerosis? Researchers studied a garlic powder tablet versus a placebo for three months. As you can see below and at 1:42 in my video, the placebo group got worse, which is what tends to happen. Eat the same artery-clogging diet, and your arteries continue to clog. However, the progression of the disease appeared to slow and even stall in the garlic group. 

    Of course, it would be nice to see the thickening of the artery wall reverse, but, for that, one might have to add more plants than just garlic to one’s diet. Still, though, that same quarter teaspoon of a simple spice available everywhere may be considered as an adjunct treatment for atherosclerosis, the number one killer of both men and women in the United States and around much of the world.

    What about garlic for high blood pressure? A systematic review and meta-analysis of randomized controlled trials “demonstrated that garlic has a statistically significant and clinically meaningful effect” on both systolic and diastolic blood pressures, reducing the top number by nearly seven and the bottom number by about five. That may not sound like a lot, but reducing diastolic blood pressure (the bottom number) by five points can reduce the risk of stroke by about a third and heart disease by 25 percent, as you can see in the graph below and at 2:38 in my video

    “Plant-based medicine provides beneficial effects, alongside with only minimal or no complications”—that is, little or no side effects—“and compared to other medicine are relatively cost-effective.” I’d say so, at as little as a penny per day.

    What else can garlic do? See related posts below.

    Here’s a tasty, garlicky recipe from The How Not to Die Cookbook: Garlic Caesar Salad Dressing

    Of course, the best way to treat heart disease is to simply get rid of it by treating the underlying cause. See How Not to Die from Heart Disease.

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • Wegovy Is Good for More Than Just Weight Loss

    Wegovy Is Good for More Than Just Weight Loss

    [ad_1]

    The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.

    The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.

    When the results of the study were first released at the American Heart Association meeting last November, the findings were greeted with a round of applause from the heart experts in attendance. Obesity is a major risk factor for heart disease, and while doctors have an arsenal of medications to treat many other risk factors—such as high blood pressure, high cholesterol, and diabetes—they haven’t had a powerful enough drug to help people lose weight until now.

    Wegovy, which was approved in 2021, is the brand name for semaglutide. Ozempic, which was approved in 2017 to treat diabetes, is a lower dosage of semaglutide; in 2020, it too received FDA approval for reducing the risk of major cardiovascular events in people with Type 2 diabetes and heart disease.

    Patients taking Wegovy inject themselves once a week in increasing doses until they reach the target dose of 2.4 mg. People with a history of thyroid cancer should not use Wegovy, since semglutide has been linked to a higher risk of that cancer in animals (though not in people). Side effects of the injections include inflammation of the pancreas, kidney problems, and depression.

    “This is an entirely new pathway to harness, of addressing obesity and its metabolic complications,” said Dr. Amit Khera, director of the Preventive Cardiology Program at the University of Texas Southwestern Medical Center, after the results on which the approval was based were released in November. “The fact that we have a new treatment avenue for patients with cardiovascular disease is incredibly exciting, and welcome.”

    [ad_2]

    Alice Park

    Source link

  • The switch to daylight saving time is unpopular – and unhealthy, experts say

    The switch to daylight saving time is unpopular – and unhealthy, experts say

    [ad_1]

    Collective groans emerge from under comforters each spring with the advent of daylight saving time and the loss of one hour’s sleep.

    A recent poll conducted by Monmouth University found that 61% of Americans wanted to get rid of the twice-a-year time change – falling back an hour each November to standard time and springing ahead each March to daylight saving. Just over one-third of people wanted to keep the back-and-forth shifts.


    MOREDrinking coffee could lower risk of obesity, study says


    Not only is switching from standard time to daylight saving the second Sunday in March wildly unpopular – it is also dangerous. Studies have shown it leads to increased behavioral health issues, cardiovascular events and traffic fatalities.

    “That one-hour change may not seem like much, but it can wreak havoc on people’s mental and physical well-being in the short term,” Dr. Charles Czeisler, a professor of sleep medicine at Harvard Medical School, told Harvard Men’s Health Watch last year.

    Pushing clocks ahead an hour increases “our exposure to morning darkness and to artificial light at night,” which disrupts our circadian rhythm, the name for the physical, mental and behavioral changes we experience over a 24-hour period, said Dr. Zhikui Wei, a specialist in sleep medicine and neurology at Thomas Jefferson University’s Sleep Disorders Center. It may take “weeks to months to adjust to the lost hour” resulting in “ongoing sleep deficiency.”

    The negative health impacts from this disruption range from mood changes to increased risk for suicide and substance abuse.

    “It’s definitely not uncommon for patients who struggle with circadian rhythm disorders to struggle with mental health disorders such as depression and anxiety,” Wei said.

    People are at higher risk for heart attacks, strokes and traffic accidents in the days following the move to daylight saving time.

    Behavioral, learning and attention issues are also common among adolescents who get less sleep. A 2015 study found that students had slower reaction times and were less able to pay attention in school in the days following the spring time change.

    These findings are why the “medical community in general has voiced support for permanent standard time,” Wei said.

    In 2020, the American Academy of Sleep Medicine published a position paper against the move from standard time to daylight saving time, stating that the “acute transition” leads to serious public health and safety risks.

    “Daylight saving time is less aligned with human circadian biology – which, due to the impacts of the delayed natural light/dark cycle on human activity, could result in circadian misalignment, which has been associated in some studies with increased cardiovascular disease risk, metabolic syndrome and other health risks,” the paper reads, ultimately advocating for the move to a fixed, year-round standard time.

    Legislation to eliminate the back-and-forth time changes has been languishing in Congress.

    Last year, Sen. Marco Rubio, of Florida, reintroduced the bipartisan Sunshine Protection Act in the U.S. Senate. It would create a permanent, national daylight saving time. But the bill, which would generally mean less light in the morning, has stalled.

    At this time, federal law still prohibits states from adopting permanent daylight saving time.

    Plus, medical experts do not support permanent daylight saving since it causes a “misalignment between social clock and internal circadian rhythm,” Wei said.

    “Many people’s circadian rhythms are somewhat resilient, but if you’re going to make a change, it would be much more favorable to go with standard time,” Dr. Patrick J. Strollo Jr., a sleep-apnea researcher and pulmonologist at the University of Pittsburgh, said in a post on the American Medical Association’s website.

    When the United States experimented with universal daylight saving time in 1973, during an energy crisis, the sun generally didn’t come up before 8 a.m. across Pennsylvania. Parents objected to their children riding buses back and forth to school in the dark.

    The shift to universal daylight saving was so unpopular that Congress halted the plan just 10 months into the experiment.

    The tug-of-war time changes began in the early 1900s to preserve energy and resources and to promote commerce. The shifting between standard and daylight saving time started and stopped several times before becoming permanent with the 1966 Uniform Time Act.

    What makes these biannual time changes especially unhealthy is that they exacerbate existing problems people have with sleep hygiene, Wei said.

    “One of the biggest challenges in modern day is that sometimes there are other priorities that may take the place of sleep,” Wei said. “But from a health perspective and a life perspective, sleep is an essential function.”

    Daylight saving time takes effect Sunday at 2 a.m., when clocks move one hour ahead.

    To help ease the transition, Wei recommended that people start waking up 15 to 30 minutes earlier each day, starting Thursday. “That way, people may have an easier time adjusting to the earlier schedule,” Wei said.

    He also suggested that people prioritize and protect their sleep even more than they normally do by:

    • Maintaining a consistent sleep schedule
    • Getting 7-9 hours of sleep a night
    • Avoiding caffeine, alcohol and smoking
    • Reducing exposure to artificial light, such as from electronic devices, at least 30 minutes to one hour before bedtime
    • Seeking professional help for any mental health issues, such as anxiety and depression

    How do you know if you need to see a sleep specialist?

    If you have trouble falling asleep, staying asleep or experience unsatisfying sleep, you might want to talk to a medical provider, Wei said.

    Other reasons to think about having a sleep assessment include experiencing mood swings or mood disturbances during the day or suffering from impaired daytime functioning and alertness.

    [ad_2]

    Courtenay Harris Bond

    Source link

  • Fighting Inflammation with Flaxseeds  | NutritionFacts.org

    Fighting Inflammation with Flaxseeds  | NutritionFacts.org

    [ad_1]

    Elevated levels of pro-inflammatory, aging-associated oxylipins can be normalized by eating ground flaxseed. 

    I previously explored the “Potent Antihypertensive Effect of Dietary Flaxseed in Hypertensive Patients” study in my video Flaxseeds for Hypertension. That was a double-blind, randomized, placebo-controlled trial where researchers disguised ground flaxseed in baked goods versus flax-free placebo muffins and saw an extraordinary drop in high blood pressure. As you can imagine, the flaxseed industry was overjoyed, praising the “impressive” findings, as was I. After all, high blood pressure is “the single largest risk factor” for death in the world. Yes, we give people medications, lots and lots of medications, but most people don’t take them. Nine out of ten people take less than 80 percent of their prescribed blood pressure pills. 
     
    It’s not difficult to understand why. “Patients are asked to follow an inconvenient and potentially costly regimen, which will likely have a detrimental effect on health-related quality of life, to treat a mostly asymptomatic condition that commonly does not cause problems for many years.” So, they may feel worse instead of better, due to the side effects. Then, some think the answer is to give them even more drugs to counteract the effects of the first drugs, like giving men Viagra to counteract the erectile dysfunction caused by their blood pressure pills. 
     
    How about using a dietary strategy instead, especially if it can be just as effective? And, indeed, the drop in blood pressure the researchers saw in the flaxseed study “was greater than the average decrease observed with the standard dose of anti-hypertensive medications.” Flaxseeds are cheaper, too, compared to even single medications, and most patients are on multiple drugs. Plus, flaxseeds have good side effects beyond their anti-hypertensive actions. Taking tablespoons of flaxseed a day is a lot of fiber for people living off of cheeseburgers and milkshakes their whole lives, and your gut bacteria may need a little time to adjust to the new bounty. So, those who start with low-fiber diets may want to take it a little slow with the flaxseeds at first. 
     
    Not all studies have shown significant blood pressure–lowering effects, though. There have been more than a dozen trials by now, involving more than a thousand subjects. And, yes, when you put them all together, overall, there were “significant reductions in both SBP and DBP”—systolic blood pressure (the upper number) and diastolic blood pressure (the lower number)—“following supplementation with various flaxseed products.” But none was as dramatic as what the researchers had found in that six-month trial. The longer trials tended to show better results, and some of the trials just used flaxseed oil or some kind of flaxseed extract. We think this is because the whole is greater than the sum of its parts. “Each of the components of interest within flaxseed, ALA, lignans, fiber, and peptides”—the omega-3s, the cancer-fighting lignans, all the soluble fiber, and the plant proteins, for instance—“all contribute towards BP reduction.” Okay, but how? Why? What is the mechanism? 
     
    Some common blood-pressure medications like Norvasc or Procardia work in part by reducing the ability of the heart to contract or by slowing down the heart. So, might it be that’s how flaxseeds work, too? But, no. In my video Benefits of Flaxseeds for Inflammation, I profile the “Dietary Flaxseed Reduces Central Aortic Blood Pressure Without Cardiac Involvement but Through Changes in Plasma Oxylipins” study. What are oxylipins? 
     
    “Oxylipins are a group of fatty acid metabolites” involved in inflammation and, as a result, have been implicated in many pro-inflammatory conditions, including aging and cardiovascular disease. “The best-characterized oxylipins about cardiovascular disease are derived from the w-6 fatty acid arachidonic acid,” a long-chain omega-6 fatty acid. These are found preformed in animal products, particularly chicken and eggs, and can be made inside the body from junky oils rich in omega-6, such as cottonseed oil, as noted below and at 3:49 in my video. But, as this study is titled, “Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption.” 

    That’s how we think flaxseed consumption reduces blood pressure in patients with hypertension: by inhibiting the enzyme that makes these pro-inflammatory oxylipins. I’ll spare you from acronym overload, but eating flaxseeds inhibits the activity of the enzyme that makes these pro-inflammatory oxylipins, called leukotoxin diols, which in turn may lower blood pressure. “Identifying the biological mechanism adds confidence to the antihypertensive actions of dietary flaxseed,” but that’s not all oxylipins do. Oxylipins may also play a role in the aging process. However, we may be able to “beneficially disrupt these biological changes associated with inflammation and aging” with a nutritional intervention like flaxseed. Older adults around age 50 have higher levels of this arachidonic acid–derived oxylipin compared to younger adults around age 20, as you can see in the graph below and at 4:56 in my video. “These elevated concentrations of pro-inflammatory oxylipins in the older age group…may…explain the higher levels of inflammation in older versus younger individuals.” As we get older, we’re more likely to be stricken with inflammatory conditions like arthritis. So, this “elevation of pro-inflammatory oxylipins…may predispose individuals to chronic disease conditions.”

    What if you took those older adults and gave them muffins, like the ones with ground flaxseed? That’s just what a group of researchers did. Four weeks later, the subjects’ levels dropped down to like 20-year-olds’ levels, as seen in the graph below and at 5:32 in my video, “demonstrating that a potential therapeutic strategy to correct the deleterious pro-inflammatory oxylipin profile is via a dietary supplementation with flaxseed.”

    What about flax and cancer? See the related posts below. 

    I also have a video on diabetes: Flaxseeds vs. Diabetes

    If you’re interested in weight loss, see Benefits of Flaxseed Meal for Weight Loss

    What about the cyanide content of flax? I answered that in Friday Favorites: How Well Does Cooking Destroy the Cyanide in Flaxseeds and Should We Be Concerned About It?.

    What else can help fight inflammation? Check out in related posts below.

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • Coffee, Tea And Good Health

    Coffee, Tea And Good Health

    [ad_1]

    Coffee and tea have been seen as villains for the body.  An entire industry has popped up around alternatives to just good coffee or a piping hot cuppa tea. There is a rough estimate the world drinks three cups of tea for every cup of coffee. And tea is the second most popular beverage in the world (behind water). Now science is indicate Coffee, tea and good health may go together.

    The study, published in PLOS Medicine, surveyed data on 360,000 people between the ages of 50 and 74, looking for their coffee and tea drinking habits and incidents of dementia and strokes over the years. After the initial survey was conducted, these same participants were followed up with 11 years later, allowing researchers to compare and contrast.

    RELATED: Coffee Protects You From This Disease According To New Research

    Photo by Kira auf der Heide via Unsplash

    The study concluded participants who drank two to three cups of any of these two drinks a day fared better than those who didn’t drink them at all. The sweet spot was found when people consumed the amount of each beverage daily (4 to 6 cups total), resulting in a 28% lower risk of dementia and 32% lower risk of a stroke.

    In an email exchange with CNN, Dr. Lee H. Schwamm, chair of the American Stroke Association Advisory Committee and chair in Vascular Neurology at Massachusetts General Hospital, explained while the study was intriguing there was no way of establishing causation from this initial data.

    RELATED: This Type Of Coffee Is Best For Your Heart Health

    “We cannot impute causality, and say ‘drinking more coffee or tea is good for your brain.’ What we can only say in this study, people who reported moderate coffee/tea drinking were less likely to have a stroke or dementia occur in the 10 years of follow-up,” he said.

    This Type Of Coffee Is Best For Your Heart Health
    Photo by Jenny Ueberberg via Unsplash

    RELATED: Here’s When You Should Drink Coffee For Maximum Productivity

    Coffee has long been associated with preventing a wide range of diseases and improving heart health. Still, it’s always important to approach caffeine in moderation, managing your coffee intake without keeping too much of a stern hold on it. When it comes to tea, studies have found links suggest lower odds of cardiovascular disease, better teeth, and even protection against cancer.

    In short, go for the warm drink in the morning, and don’t overthink it if you get the urge to have more later on in the day.

    [ad_2]

    Maria Loreto

    Source link

  • How Safe Is Alternate-Day Intermittent Fasting?  | NutritionFacts.org

    How Safe Is Alternate-Day Intermittent Fasting?  | NutritionFacts.org

    [ad_1]

    Eating every other day can raise your cholesterol. 
     
    Are there any downsides to fasting every other day? For example, might go all day without eating impair your ability to think clearly? Surprisingly, as I discuss in my video Is Alternate-Day Intermittent Fasting Safe?, the results appear to be “equivocal.” Some studies show no measurable effects and the ones that do fail to agree on which cognitive domains are affected. Might the cycles of fasting and feasting cause eating disorder–type behaviors, like bingeing? So far, no harmful psychological effects have been found. In fact, there may be some benefit. However, the studies that have put it to the test specifically excluded those with a documented history of eating disorders, for whom the effects may differ. 
     
    What about bone health? No change in bone mineral density was noted after six months of alternate-day fasting despite about 16 pounds of weight loss, which would typically result in a dip in bone mass. However, the researchers did not note any skeletal changes in the control group either, and they lost a similar amount of weight using continuous caloric restriction. They suggested this is because both groups tended to be “more physically active than the average obese American,” getting about 1,000 to 2,000 more steps a day. 
     
    Proponents of intermittent fasting suggest it can better protect lean body mass, but most of the intermittent trials have employed less accurate methods of body composition analysis, whereas the majority of continuous caloric restriction trials used “vastly more accurate techniques.” So, to date, it is not clear if there’s a difference in lean mass preservation. 
     
    Improvements in blood pressure and triglycerides have been noted on intermittent fasting regimens, though this is presumed to be due to the reduction in body fat since the effect appears to be “dependent on the amount of weight lost.” Alternate-day fasting can improve artery function, too, as you can see in the graph below and at 1:55 in my video, though it does depend on what you’re eating on the non-fasting day. For study participants randomized to an alternate-day diet high in saturated fat, their artery function worsened despite a ten-pound weight loss, whereas it improved, as expected, in the lower-fat group. The decline in artery function was presumed to be because of the pro-inflammatory nature of saturated fat. 

    A concern has been raised about the effects of alternate-day fasting on cholesterol. After 24 hours without food, LDL cholesterol may temporarily bump up, but this is presumably because so much fat is being released into the system by the fast. As you can see in the graph below and at 2:33 in my video, an immediate negative effect on carbohydrate tolerance may stem from the same phenomenon—the repeated elevations of free fat floating around in the bloodstream. After a few weeks, though, LDL levels start to drop as the weight comes off. However, results from the largest and longest trial of alternate-day fasting have given me pause. 


    A hundred obese men and women were randomized into one of three groups: alternate-day modified fasting (25 percent of their baseline calories on fasting days and 125 percent calories on eating days), continuous, daily caloric restriction (75 percent of baseline), or a control group instructed to maintain their regular diet. So, for those going into the trial eating 2,000 calories a day, they would continue to eat 2,000 calories a day in the control group. The calorie-restriction group would get 1,500 calories every day, and the intermittent-restriction group would alternate between 500 calories a day and 2,500 calories the next. 
     
    As you can see in the graph below and at 3:32 in my video, with the same overall, average, prescribed calorie cutting in the two weight-loss groups, they both lost about the same amount of weight, but, surprisingly, the cholesterol effects were different. In the continuous calorie-restriction group, the LDL levels dropped as expected compared to the control group as the pounds came off. 

    But, in the alternate-day modified fasting group, they didn’t, as you can see below, and at 3:55 in my video. At the end of the year, the LDL cholesterol in the intermittent fasting group ended up being 10 percent higher than in the constant calorie-restriction group—despite the same loss of body fat. Given that LDL cholesterol is a prime causal risk factor for heart disease, our number one killer—or is even the prime risk factor—this strikes a significant blow against alternate-day fasting. If you want to try it anyway, I would advise you to have your cholesterol monitored to make sure it comes down with your weight. 


    If you’re diabetic, you must talk with your physician about medication adjustment for any changes in diet, including fasting of any duration. Even with proactive medication reduction, advice to immediately break the fast should sugars drop too low, and weekly medical supervision, people with type 2 diabetes who fasted for even just two days a week were twice as likely to suffer from hypoglycemic episodes compared to an unfasted control group. We still don’t know the best way to tweak blood sugar medications to prevent blood sugar from dropping too low on fasting days. 
     
    Even fasting for just one day can significantly slow the clearance of some drugs (like the blood-thinning drug Coumadin) or increase the clearance of others (like caffeine). Fasting for 36 hours can cut your caffeine buzz by 20 percent. So, consultation with your medical professional before fasting is an especially good idea for anyone on any kind of medication. 

    If you missed it, check out Alternate-Day Intermittent Fasting Put to the Test
     
    So, with ambiguous cognitive, lean mass, and bone effects, plus these cholesterol findings, I wouldn’t suggest alternate-day fasting for weight loss, but dropping pounds isn’t the only thing this way of eating is purported to do. Check out Does Intermittent Fasting Increase Human Life Expectancy?
     
    For other types of intermittent fasting, total fasting, and more on fasting, check out the related videos below. 



    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • The Safety of Fasting to Lose Weight  | NutritionFacts.org

    The Safety of Fasting to Lose Weight  | NutritionFacts.org

    [ad_1]

    Why should fasts lasting longer than 24 hours and particularly for three or more days only be done under the supervision of a health professional and preferably in a live-in clinic? 
     
    Fasting for a week or two can actually interfere with the loss of body fat, as shown at the start of my video Is Fasting for Weight Loss Safe?. But, eventually, after the third week of fasting, fat loss starts to overtake the loss of lean body mass in obese individuals, as seen in the graph below and at 0:14 in my video. Is it safe to go that long without food? 

    Proponents speak of fasting as a cleansing process, but some of what is being purged from our bodies are essential vitamins and minerals. People who are heavy enough can fast up to 382 days without calories, but no one can go even a fraction of that long without vitamins. Scurvy, for example, can be diagnosed within as few as four weeks without any vitamin C. Beriberi, deficiency of thiamine (vitamin B1), may start even earlier in fasting patients. And, once it manifests, it can result in brain damage within days, which can eventually become irreversible.  
     
    Even though fasting patients report problems such as nausea and indigestion after taking supplements, all of the months-long fasting cases I’ve discussed previously were given daily multivitamins and mineral supplementation as necessary. Without supplementation, hunger strikers and those undergoing prolonged fasts for therapeutic or religious purposes (like the Baptist pastor hoping “to enhance his spiritual powers for exorcism”) have ended up paralyzed, become comatose, or worse. 
     
    Nutrient deficiencies aren’t the only risk. After reading about all of the successful reports of massive weight loss from prolonged fasting in the medical literature, one doctor decided to give it a try with his patients. Of the first dozen he tried it on, two died. In retrospect, the two patients who died had started out with heart failure and had been on diuretics. Fasting itself produces pronounced diuresis, meaning loss of water and electrolytes through the urine, so it was the combination of fasting on top of the water pills that likely depleted their potassium and triggered their fatal heart rhythms. The doctor went out of his way to point out that both of the people who died started out “in severe heart failure, complicated by gross obesity; but both had improved greatly whilst undergoing starvation therapy.” That seems like a small consolation since they were both dead within a matter of weeks. 
     
    Not all therapeutic fasting fatalities were complicated by concurrent medication use, though. One researcher writes: “At first he did very well and experienced the usual euphoria…His pulse, blood pressure, and electrolytes remained satisfactory, but in the middle of the third week of treatment, he suddenly collapsed and died. This line of treatment is certainly tempting because it does produce weight loss and the patient feels so much better, but the report of case-fatalities”—the whole part about killing people—“must make it a very suspect line of management.” 
     
    Contrary to the popular notion that the heart muscle is specially spared during fasting, the heart appears to experience similar muscle wasting. This was “described in the victims of the Warsaw ghetto” during World War II in a remarkable series of detailed studies carried out by the ghetto physicians before they themselves succumbed. In a case entitled “Gross Fragmentation of Cardiac Fiber After Therapeutic Starvation for Obesity,” a 20-year-old woman successfully “achieved her ideal weight” after losing 128 pounds by fasting for 30 weeks. “After a breakfast of one egg,” she had a heart attack and died. On autopsy, as you can see below and at 3:44 in my video, the muscle fibers in her heart showed evidence of widespread disintegration. The pathologists suggested that fasting regimens “should no longer be recommended as a safe means of weight reduction.” 
    Breaking the fast appears to be the most dangerous part. After World War II, as many as one out of five starved Japanese prisoners of war tragically died following liberation. Now known as “refeeding syndrome,” multiorgan system failure can result from resuming a regular diet too quickly. This is because there are critical nutrients such as thiamine and phosphorus that are used to metabolize food. Therefore, in the critical refeeding window, if too much food is taken before these nutrients can be replenished, demand may exceed supply. Whatever residual stores you still carry can be driven down even further, with potentially fatal consequences. This is why rescue workers are taught to always give thiamine before food to victims who have been trapped or otherwise unable to eat. Thiamine is responsible for the yellow color of “banana bags,” a term you might have heard used in medical dramas to describe an IV fluid concoction often given to malnourished alcoholics to prevent a similar reaction. (You can see a photo of them below and at 4:53 in my video.) Anyone “with negligible food intake for more than five days” may be at risk of developing refeeding problems. 
    Medically-supervised fasting has gotten much safer now that there are proper refeeding protocols. We now know what warning signs to look for and who shouldn’t be fasting in the first place, such as those who have advanced liver or kidney failure, porphyria, uncontrolled hyperthyroidism, and pregnant and breastfeeding women. The most comprehensive safety analysis of medically supervised, water-only fasting was recently published by the TrueNorth Health Center in California. Out of 768 visits to its facility for fasts up to 41 days, were there any adverse events? There were 5,961 of them! Most of these were mild, known reactions to fasting, such as fatigue, nausea, insomnia, headache, dizziness, upset stomach, and back pain. Only two serious events were reported, and no fatalities. You can see the chart below and at 5:58 in my video
    Fasting periods lasting longer than 24 hr, and particularly those lasting 3 or more days, should be done under the supervision of a physician and preferably in a [live-in] clinic.” In other words, don’t try this at home! This is not just legalistic mumbo-jumbo. For example, normally, your kidneys dive into sodium conservation mode during fasting, but should that response break down, you could rapidly develop an electrolyte abnormality that may only manifest with non-specific symptoms, like fatigue or dizziness, which could easily be dismissed until it’s too late. 
     
    The risks of any therapy must be premised on the severity of the disease. The consequences of obesity are considered so serious that effective therapies could have “considerable acceptable toxicity.” For example, many consider major surgery for obesity to be a justifiable risk, but the keyword is effective. 
     
    Therapeutic fasting for obesity has largely been abandoned by the medical community not only because of its uncertain safety profile but its questionable short- and long-term efficacy. Remember, for a fast that only lasts a week or two, you might be able to lose as much body fat or even more on a low-calorie diet than a no-calorie diet. 
     
    Fasting for a week or two can actually interfere with the loss of body fat. For more background on this, see Is Fasting Beneficial for Weight Loss? and Benefits of Fasting for Weight Loss Put to the Test.
     
    If you’re wondering what the best way to lose weight is, I wrote a whole book about it! Check out How Not to Diet
     
    Interested in learning more about fasting? See related videos below. 

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • Flavonoid Benefits from Apple Peels  | NutritionFacts.org

    Flavonoid Benefits from Apple Peels  | NutritionFacts.org

    [ad_1]

    Peeled apples are pitted head-to-head against unpeeled apples (and spinach) in a test of artery function. 

    Regularly eating apples may contribute to a lower risk of dying prematurely. “Moderate apple consumption,” meaning one or two apples a week, “was associated with a 20% lower risk of all-cause mortality”—that is, dying from all causes put together—“whereas those who ate an apple a day had a 35% lower risk of all-cause mortality compared with women with low apple consumption.” 
     
    You’ll often hear me talking about a lower or higher risk of mortality, but what does that mean? Isn’t the risk of dying 100 percent for everyone, eventually? As you can see in my graph below and at 0:40 in my video Friday Favorites: For Flavonoid Benefits, Don’t Peel Apples, I present some survival curves to help you visualize these concepts. For example, if you follow thousands of older women over time, nearly half succumb over a period of 15 years, but that half includes those who rarely, if ever, ate apples—less than 20 apples a year. Instead, those averaging more like half a small apple a day lived longer; over the same time period, closer to 40 percent or so of them died. And, those who ate one small apple or about a quarter of a large apple a day survived even longer. 

    Why is that the case? It seems to be less the apple of one’s eye than the apple of one’s arteries. Even a fraction of an apple a day is associated with 24 percent lower odds of having severe major artery calcifications, a marker of vascular disease. You may think that’s an obvious benefit since apples are fruits and fruits are healthy, but the effect was not found for pears, oranges, or bananas. 
     
    Both of these studies were done on women, but a similar effect (with apples and onions) was found for men. We think it’s because of the flavonoids, naturally occurring phytonutrients concentrated in apples. As you can see below and at 2:02 in my video, they’re thought to improve artery function and lower blood pressure, leading to improvements in blood flow throughout the body and brain, thereby decreasing the risk of heart disease and strokes. You don’t know, though, until you put it to the test.


    When I first saw a paper on testing flavonoid-rich apples, I assumed they had selectively bred or genetically engineered a special apple. But, no. The high-flavonoid apple was just an apple with its peel, compared to the low-flavonoid apple, which was the exact same apple with its peel removed. After eating the apples, flavonoid levels in the bloodstream shot up over the next three hours in the unpeeled apple group, compared to the peeled group, as you can see below, and at 2:36 in my video. This coincided with significantly improved artery function in the unpeeled apple group compared to the peeled one. The researchers concluded that “the lower risk of CVD [cardiovascular disease] with higher apple consumption is most likely due to the high concentration of flavonoids in the skin which improve endothelial [arterial] function”—though, it could be anything in the peel. All we know is that apple peels are particularly good for us, improving artery function and lowering blood pressure. 
    Even compared to spinach? As you can see in the graph below and at 3:14 in my video, if you give someone about three-quarters of a cup of cooked spinach, their blood pressure drops within two to three hours. If you instead eat an apple with some extra peel thrown in, you get a similar effect. The researchers concluded that apples and spinach almost immediately improve artery function and lower blood pressure. 
    What’s nice about these results is that we’re talking about whole foods, not some supplement or extract. So, easily, “this could be translated into a natural and low-cost method of reducing the cardiovascular risk profile of the general population.” 

    For more about apples, see the topic page and check out the related videos below. 

    What about dried apples? See Dried Apples vs. Cholesterol. What about apple cider vinegar? Check out Flashback Friday: Does Apple Cider Vinegar Help with Weight Loss?. And what about apples going head-to-head with açai berries? See The Antioxidant Effects of Açai vs. Apples.

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • The 4 New Year’s Resolutions Cardiologists Always Make

    The 4 New Year’s Resolutions Cardiologists Always Make

    [ad_1]

    It’s the season when many people set New Year’s resolutions for the year ahead, and these goals are often related to physical health.

    Experts say there’s one big area that many people should focus on when it comes to their well-being: cardiovascular health.

    “Cardiovascular disease is the number one cause of death in America,” said Dr. William Cornwell, a cardiologist at UCHealth University of Colorado Hospital. “And, sadly, people… lack a clear understanding of the health or unhealth of their hearts until something catastrophic happens, such as a heart attack or a stroke.”

    But there are lifestyle habits you can adopt to manage some of the factors ― like high cholesterol, diabetes and high blood pressure ― that put you at risk of heart attack and stroke.

    Cardiologists say they encourage these lifestyle habits every year. Below, doctors shared with HuffPost the New Year’s resolutions they set and recommend to patients in the name of heart health.

    Committing or recommitting to exercise.

    No surprise here: All of the experts we spoke to said exercise is an important resolution to set every single year.

    “First and foremost, from a cardiac standpoint regarding cardiovascular health, exercise needs to be at the forefront,” Cornwell said.

    “For me, personally, it is a part of my everyday routine and every year,” he said. “There needs to be a renewed commitment to ensure that exercise is at the forefront of everything that you should be thinking about to improve or maintain your cardiac health.”

    “Exercise also brings a number of other benefits to other organ systems, in addition to improvements in quality of life and your overall ability to function well without symptoms,” Cornwell noted. “So, for many reasons — the heart really only being one of many — if there was going to be one New Year’s resolution, exercise should be the one.”

    Admittedly, it can be hard to jump into fitness in January, a month marked by early sunsets and cold temperatures in much of the country. But it’s still important to prioritize movement during this time of year, said Dr. Johanna Contreas, a member of the National Hispanic Medical Association and a cardiologist at Mount Sinai Health System in New York.

    “Winter months, we tend to see an increase in cardiovascular disease and heart attacks and heart failure, hospitalization,” Contreas said, “because those winter months, you’re more indoors, less likely to be active. So, we always try to tell patients: Think about ways that you can remain active.”

    In other words, your version of exercise does not have to take the form of an outdoor run or walk. You could focus on walking up and down the stairs throughout the day, making a point to get up from your computer after long meetings, or signing up for a fitness app that allows you to exercise from home. (Peloton, Alo Moves and FitOn are all good options.)

    As for how much you need to exercise each week, Cornwell said the American Heart Association’s guidelines recommend 150 to 300 minutes of mild to moderate-intensity exercise (like brisk walking, doubles tennis or gardening), or 75 to 150 minutes of vigorous exercise (like running, jumping rope or swimming laps), each week.

    Daniel de la Hoz via Getty Images

    Making small adjustments to your cooking regimen can create meaningful change — like not eating meat one day a week, or mixing cauliflower in with your rice.

    Knowing their numbers.

    “I tell people, [if] you really want to start a healthy year, know your numbers and know what is healthy for you,” Contreas said.

    When talking about “numbers,” experts are referring to things like a person’s blood pressure, cholesterol and fasting glucose, said Dr. Elizabeth Jackson, director of the cardiovascular outcomes and effectiveness research program at the University of Alabama at Birmingham Medicine.

    High cholesterol and high blood pressure can put you at increased risk for heart attack and stroke, which means they’re important to manage through medication and/or lifestyle changes.

    Jackson also recommends “knowing your fasting glucose, because we know that in the U.S. we have a high prevalence of diabetes, but we also have a high prevalence of pre-diabetes — people who are not quite meeting the definition of diabetes, but they’re not in the normal range.”

    According to Johns Hopkins Medicine, having diabetes makes you two to four times more likely to develop cardiovascular disease.

    You can ask your doctor for your numbers, and they can either share the data they have on file or order tests to determine this information.

    “It’s important to know where you’re at in terms of those numbers, but also not to be discouraged if numbers are out of whack,” Jackson noted.

    You can get to a healthier place by adhering to lifestyle adjustments like sticking to an exercise regimen, quitting smoking, and more ways that are outlined in the AHA’s Life Essential 8. Additionally, you can talk to your doctor about medication to see if that’s the right choice for you.

    Focusing on their nutrition.

    Eating a nutritious diet full of things like fruits, veggies, whole grains, lean protein and beans is known to be beneficial for your heart health and your health overall.

    According to Jackson, thinking wholeheartedly about your diet is a good goal for the new year.

    To focus on your nutrition, Jackson suggests food-prepping for the week so you’ll have something nutritious to grab when you’re hungry. She also suggests trying out new heart-health recipes each week. The American Heart Association has recipes, she noted, that can help maintain or improve your cardiac health.

    If this feels too daunting, Contreas said, you can try simple hacks like adding vegetables to your rice to make your meals more nutritious. Additionally, you could try eating vegetarian a few days a week, or even for a few meals a week.

    Contreas noted that it’s important to be mindful of your salt intake, too. Consuming too much salt can increase your blood pressure, she said.

    And, as mentioned above, high blood pressure can put you at risk for heart attack and stroke.

    Prioritizing sleep.

    “Sleep is very important,” Contreas said. “Sleep deprivation, we know now, is very unhealthy, and it can cause increasing cardiovascular disease” and put you at higher risk for depression and high blood pressure.

    Contreas said one of her New Year’s resolutions is to help workers at her hospital get better sleep, in particular those who have to work the night shift.

    It’s recommended that adults get between seven and nine hours of sleep each night. “It may not be possible every night,” Contreas acknowledged. “But as much as we can stick to [it] would be important.”

    Jackson and Cornwell both pointed out that healthy sleep is part of the AHA’s guidelines to better cardiovascular health, and is an important goal to focus on every year.

    One tip: Don’t give up on these goals if you get distracted from time to time.

    “We don’t have to go and be perfect every day right away,” Jackson said. “It’s not like January 1 starts, and all of a sudden your lifestyle habits are going to change dramatically and never go back.”

    You should cut yourself some slack if you miss a day at the gym or fall back into an old habit you’re trying to break. Additionally, it’s OK to let yourself have rest days (your body needs them!) and allow yourself desserts and foods that aren’t particularly heart-healthy, too.

    “But, knowing that if you’re putting in more healthy-type behaviors — healthy diet, physical activity, good sleep — most days, or more than you were, then that’s contributing,” Jackson said. “It really adds up.”

    Missing a workout, or having a meal that isn’t great for your high cholesterol, isn’t going to put you back at zero.

    “Our cardiovascular health is not just turning on a switch. It’s a holistic view of your diet, your physical activity, your sleep patterns, your lifestyle, together with those numbers for those traditional risk factors of blood glucose, blood pressure, cholesterol,” Jackson said. “It’s really something that is a lifestyle, something to follow and think about your whole life.”

    [ad_2]

    Source link

  • What to Know About Heart Failure When You Have Diabetes

    What to Know About Heart Failure When You Have Diabetes

    [ad_1]

    In June of 2022, a report from the American Diabetes Association highlighted heart failure as “an underappreciated complication of diabetes.” According to that report, up to 22% of people with diabetes will develop heart failure, and the incidence of heart failure within the diabetes community is increasing.

    “Heart failure is the most prevalent cardiovascular complication in people with diabetes,” says Dr. Rodica Pop-Busui, a professor of diabetes at the University of Michigan and president of medicine and science at the American Diabetes Association. “In the U.S. alone there are 37 million people diagnosed with diabetes, and heart failure in this population is a very serious health care problem that needs to be addressed before it reaches more advanced and more costly stages.” 

    For a time, it was thought that heart failure might mainly affect people with Type 2 diabetes. But the latest research suggests that people with Type 1 diabetes are also at risk. “When you look at all people with diabetes, either Type 1 or Type 2, the incidence of heart failure is four times higher than it is in the general population,” says Dr. Amgad Makaryus, a professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York.

    The term “heart failure” refers to problems with the heart muscle’s ability to pump blood. These problems can deprive other parts of the body of sufficient oxygen and blood. They can also cause fluid buildup in the lungs, abdomen, and limbs. Heart failure can produce a wide range of symptoms, and it can also lead to organ damage or sudden death. Heart failure is not only more common in people with diabetes than in the general population, but it may be more deadly. A study of more than 36,000 people in the European Journal of Heart Failure found that median survival was reduced by more than a year among those who had both heart failure and Type 2 diabetes compared to those with heart failure alone. 

    Here, experts explain the connection between the two medical conditions. They detail the heart failure signs and symptoms to watch out for if you have diabetes, and the best available courses of treatment. They also offer advice for people with diabetes who want to lower their risks for heart failure.

    The connection between heart failure and diabetes

    Among people with diabetes, glucose (also known as blood sugar) does not move out of the blood and into the cells the way it should. This leads to elevations of both blood glucose and insulin, which is a hormone that helps clear the blood of glucose. These elevations may contribute to the development of heart failure in some people with diabetes. “Elevations in glucose levels and elevations in insulin levels can cause damage at a molecular level to cells of the heart,” Makaryus says. 

    But that’s far from the only connection between the two conditions. “Mechanistically, there are several processes that affect people with diabetes that raise their risk for heart failure,” says Dr. James Januzzi, a professor of medicine at Harvard Medical School and a clinical cardiologist at Massachusetts General Hospital. Januzzi says that, besides increasing risk for coronary artery disease, diabetes can cause direct injury to the heart muscle, resulting in stiffening and weakening that can culminate in heart failure. Research has linked diabetes to mitochondrial dysfunction, oxidative stress, inflammation, and an increase in the formation of harmful compounds called advanced glycation end products, or AGEs—all of which can contribute to the development of heart failure. “Diabetes is associated with a shift from glucose-related metabolism in the heart to the production of the sugar alcohol sorbitol, which may lead to cell death with scarring of the heart muscle,” Januzzi explains. “We also know that individuals with diabetes are at higher risk for chronic kidney disease, which is an independent risk factor for heart failure.” For all of these reasons, he says that the mere presence of diabetes is now considered a primary risk factor for heart failure.

    Read More: How Stress Affects Your Heart Health

    Signs and symptoms of heart failure

    The symptoms of heart failure tend to be the same whether or not a person has diabetes. Fatigue lands at or near the top of the list, although at first this symptom may be subtle. “Someone may just feel like they don’t have the same energy they used to,” Januzzi says. Shortness of breath is another cardinal symptom of heart failure, but this may be difficult to spot if a person’s fatigue has caused them to cut down on physical activity. “Frequently I’ll ask a patient if they get shortness of breath and they’ll say no, but it’s because they’ve reduced their activity,” he says. As heart failure progresses, these symptoms tend to become much more noticeable. For example, shortness of breath can show up even after very mild physical activity, such as walking up a few stairs.  

    “Another classic sign is not just shortness of breath when you exercise, but shortness of breath when you’re lying down, or that wakes you from sleep,” says Makaryus. “This has to do with fluid overload in the lungs as a result of the heart not pumping the way it should.” Fluid overload can also lead to swelling (or edema) in the legs or abdomen of people with heart failure, he says.

    While those are the most common symptoms, others include wheezing, weakness, a rapid or irregular heartbeat, nausea, weight gain, problems thinking or concentrating, and a persistent unexplained cough (that may or may not bring up white or pink mucous). As heart failure becomes more advanced, all these symptoms tend to be less subtle. “The fatigue may become so great that someone can’t complete their daily activities,” Makaryus says.  

    It’s important to note that many cases of heart failure pass through an early stage when there are no noticeable symptoms. However, at this stage the condition may already be detectable using certain blood tests. “We now have sensitive and specific biomarkers that can identify the earliest molecular changes in the heart that precede more overt structural change,” Pop-Busui says. There are drug therapies available that are proven to reduce the progression of heart failure, and catching the condition at this early, asymptomatic stage can help doctors improve outcomes for their patients. On the other hand, some diabetes medications can contribute to the development of heart failure. If the condition is caught early, someone with diabetes can get off these drugs before the condition progresses. “Early diagnosis can help make sure that people with diabetes have access to the best treatments at the right time,” Pop-Busui says. 

    Treatment options

    The standard, first-line treatments for heart failure are medications, and experts say the drugs they choose are based on the severity of the condition. “We look at something called the ejection fraction, or the squeezing strength of the heart, to determine the appropriate treatment plan,” Januzzi says. 

    If a patient’s ejection fraction is reduced—meaning their heart is not pumping as strongly as it should—treatment usually includes several classes of drug that are designed to widen blood vessels and improve blood flow. “There are four main classes of therapy we recommend,” he says. These include beta blockers, aldosterone blockers, a medication called sacubitril/valsartan that widens blood vessels, and what’s known as an SGLT-2 inhibitor, which not only lowers blood pressure but also helps reduce blood glucose levels. (SGLT-2 inhibitors are often used to treat diabetes even absent heart failure.)

    “For people with preserved ejection fraction, meaning anormal squeezing strength, therapeutic options are more limited,” Januzzi says. “However, recent clinical trials of SGLT-2 inhibitors showed benefit in these individuals, so these should be now considered in anyone with heart failure, but especially in people with diabetes.” 

    “In my opinion, these are very important drugs,” Makaryus says of SGLT-2 inhibitors. “Initially these were marketed as diabetes medications because they have blood sugar lowering effects, but clinical trials have found they improve outcomes and all-cause mortality from major cardiovascular events, including heart failure.” He says that another newer class of drug called GLP-1 agonists has also demonstrated benefit in people with both diabetes and heart failure, and is likely to be used more frequently to treat these co-occurring conditions. 

    The drugs used to treat heart failure in people with diabetes are often the same drugs prescribed for those without diabetes, but there’s evidence that they work even better in people with both conditions. “I tell my patients with diabetes they can expect even larger reductions in risk than someone without diabetes,” Januzzi says.  

    Apart from drugs, lifestyle and behavioral changes can make a meaningful difference for people with heart failure. “This includes increasing exercise whenever possible,” Januzzi says. “This also includes paying attention to one’s mood.” Depression and anxiety are both associated with poorer outcomes in people with heart failure, he says, so it’s necessary to address these mental health challenges (with therapy, for example) if they appear. 

    “Diet and weight loss are also critically important,” Januzzi says. “At our institution, we often recommend a Mediterranean-style diet that includes more complex carbohydrates and a judicious amount of protein.” While there’s a lot of strong research supporting the health benefits of Mediterranean-style diets, he notes that people with diabetes and heart failure should ideally work with a medical dietitian or nutritionist to create a custom eating plan. “Each individual patient has their own set of medical issues that might need to be considered,” he says. There’s no optimal, one-size-fits-all diet for people with diabetes and heart failure.

    Read More: How COVID-19 Changes the Heart—Even After the Virus Is Gone

    Preventing heart failure

    While everyone should prioritize heart health, taking steps to lower your risks for heart failure is especially important if you’ve been diagnosed with diabetes. “Even for those individuals with relatively new-onset diabetes, the condition may have been present for a while, and so the clock has already been ticking,” Januzzi says. “There’s no better time than now to focus on wellness.”

    Controlling your risk factors for heart failure is step one, and that means not smoking, first and foremost, and also managing your cholesterol, blood pressure, and blood glucose through a combination of diet, exercise, weight loss, and medication therapy. “I also encourage my patients with diabetes to educate themselves so they understand their condition and the early warning signs of heart failure,” Januzzi says. Keeping yourself informed on the latest regarding your disease, your risk factors, your medication options, and your screening options is still a good idea. “I always advise my patients to be their own advocates,” he adds.

    Heart failure is a common complication for people with diabetes. But with the right plan, you and your care team can take steps to effectively prevent or treat the condition.

    [ad_2]

    Markham Heid

    Source link

  • The Future of Obesity Drugs Just Got Way More Real

    The Future of Obesity Drugs Just Got Way More Real

    [ad_1]

    A wild idea recently circulated about the future of aviation: If passengers lose weight via obesity drugs, airlines could potentially cut down on fuel costs. In September, analysts at Jefferies Bank estimated that in the “slimmer society” obesity drugs will create, United Airlines could save up to $80 million in jet fuel annually.

    In the past year, as more Americans have learned about semaglutide, which is sold for diabetes under the brand name Ozempic and for obesity under the name Wegovy, hype has become completely divorced from reality. For all the grand predictions, just a fraction of Americans who qualify for obesity drugs are on them. With a list price of roughly $1,350 a month, Wegovy is far too expensive, under-covered by insurance, and in limited supply to be a routine part of health care.

    But that possibility is beginning to seem very real. The results of a highly anticipated study published on Saturday indicate that Wegovy can have profound effects on heart health, which potentially opens up the drug to even more patients. A few days earlier, the FDA approved Zepbound, an obesity drug that is a bit cheaper and appears more potent than Wegovy. If there was any doubt before, now it is undeniable: Obesity drugs “are here to stay,” Kyla Lara-Breitinger, a cardiologist at the Mayo Clinic, told me. “There’s only going to be more and more of them.” They are now poised to become deeply entrenched in American health care, perhaps eventually even joining the ranks of commonly used drugs such as statins and metformin.

    Considering that obesity is linked to all sorts of major heart ailments, it is no big surprise that a weekly shot for weight loss might have some cardiovascular benefits. But because this class of obesity drugs, known as GLP-1 agonists for the hunger hormone they target, is so new, doctors did not know that for sure. Starting in 2018, Novo Nordisk, the company that manufactures semaglutide, began to look for answers in a study of more than 17,600 people with obesity and cardiovascular disease. In this group, results of a trial named SELECT show that Wegovy reduced the risk of major cardiac events—stroke, heart attack, death—by 20 percent. Even compared with studies on common heart medications such as Praluent and Repatha, the Wegovy results are “impressive,” Eugene Yang, a cardiologist and professor of medicine at the University of Washington, told me.

    How exactly the drug prevents major cardiac events isn’t fully understood. Some of the effects can likely be chalked up to weight loss itself, which is associated with improvements in metrics that influence heart health, such as blood pressure, Yang said. But mechanisms independent of weight loss may also be at work. In the trial, lower rates of cardiovascular events began showing up before participants lost weight. One explanation is the drug’s impact on inflammation, which is associated with heart disease: C-reactive protein, a rough proxy for inflammation, dropped by nearly 40 percent in study participants.

    Regardless of how Wegovy works, Yang said, “it has the potential benefit of being very significant” as a new line of treatment for heart disease, the leading cause of death nationwide. Novo Nordisk has already applied for expanded FDA approval and anticipates receiving it within six months. Approval would also show that Wegovy has a medical benefit beyond weight loss, pressuring insurers to cover it. Right now, for instance, Medicare does not, in part because obesity has long been viewed as a cosmetic issue, not a medical one. Even with private coverage, the drug is still frequently out of reach. The SELECT trial makes it “unequivocally clear” that obesity is a health condition that can be treated with drugs, Ted Kyle, an obesity-policy expert, told me. Still, the study leaves room for pushback: The absolute risk reduction of cardiovascular events was 1.5 percent, which is, by some reckonings, quite small. A higher risk reduction would have “put more pressure” on insurers and manufacturers to make the drugs more affordable for Americans, Lara-Breitinger said.

    Still, the findings are robust enough that it seems likely that the heart benefits of obesity drugs will lead more Americans to take them—if not immediately, then eventually. The approval of a new drug could do the same. Tirzepatide, which Eli Lilly has sold as a diabetes drug under the name Mounjaro, will be marketed as Zepbound for obesity—and it is coming for Wegovy’s throne. In one study, people on tirzepatide lost an average of 18 percent of their body weight; for comparison, in another study patients on Wegovy lost an average of 15 percent. At a little over $1,000 a month, Zepbound is not cheap, but its list price is hundreds of dollars lower than that of Wegovy. (The manufacturers of both drugs have said that most insured patients pay far less than that.)

    Zepbound’s approval is just the beginning. Unlike semaglutide, which targets only one hormone, GLP-1, to exert its effects on appetite and fullness, tirzepatide targets two. Other drugs that target two or even three hormones are in the works, as are versions that come in a more appealing pill format rather than as an injection. Generic versions of these drugs, likely beginning with liraglutide, a predecessor to semaglutide sold as Saxenda, could become available soon, Yang said. This competition will help bring down costs, but it will go only so far. Drug pricing is “a little bit screwy,” Kyle said, complicated by the wide gap between the list price and the net price created by manufactures, insurers, and intermediaries between them.

    Each new competitor and new study is a step toward a future in which a substantial proportion of Americans with obesity are routinely prescribed these drugs. In a single week, obesity drugs leapt a new era—one in which they are about to become significantly more mainstream. No doubt that future is a bright one for millions of people who might benefit from treatment. Still, many questions about the drugs remain unanswered, such as their long-term safety and endless supply shortages.

    But the potential for obesity drugs to truly change America has never felt closer—with all of the dizzying questions this creates about what “a slimming society” might mean for exercise, the food industry, and apparently even airline jet fuel.

    [ad_2]

    Yasmin Tayag

    Source link

  • Is It Safe to Take Weight-Loss Pills?  | NutritionFacts.org

    Is It Safe to Take Weight-Loss Pills?  | NutritionFacts.org

    [ad_1]

    Why don’t more people take the weight-loss medications currently on the market? 

    Despite the myriad menus of FDA-approved medications for weight loss, they’ve only been prescribed for about 1 in 50 patients with obesity. We tend to worship medical magic bullets in the United States, so what gives? As I discuss in my video Friday Favorites: Are Weight-Loss Supplements Safe and Effective?, one of the reasons anti-obesity drugs are so “highly stigmatized is that, historically, they’ve been anything but magical and the bullets have been blanks—or worse. 

    To date, most weight-loss drugs that were initially approved as safe have since been pulled from the market for unforeseen side effects that turned them into a “threat to public health.” As you may remember from my video Brown Fat: Losing Weight Through Thermogenesis, it all started with DNP, a pesticide with a promise to safely melt away fat that melted away people’s eyesight instead. (That actually helped lead to the passage of the landmark Food, Drug, and Cosmetic Act in 1938.) Thanks to the internet, DNP has made a comeback with “predictably lethal results.” 

    Then came the amphetamines. Currently, more than half a million Americans may be addicted to amphetamines like crystal meth, but the “original amphetamine epidemic was generated by the pharmaceutical industry and medical profession.” By the 1960s, drug companies were churning out about 80,000 kilos of amphetamines a year, which is nearly enough for a weekly dose for every man, woman, and child in the United States. Billions of doses a year were prescribed for weight loss, and weight-loss clinics were raking in huge profits. A dispensing diet doctor could buy 100,000 amphetamine tablets for less than $100, then turn around and sell them to patients for $12,000.  

    At a 1970 Senate Hearing, Senator Thomas Dodd (father of “Dodd-Frank” Senator Chris Dodd) suggested that America’s speed freak problem “was no by means an ‘accidental development’: ‘Multihundred million dollar advertising budgets, frequently the most costly ingredient in the price of a pill, have, pill by pill, led, coaxed and seduced post-World War II generations into the ‘freaked-out’ drug culture…’” I’ll leave drawing the Big Pharma parallels to the current opioid crisis as an exercise for the viewer.  

    Aminorex was a widely-prescribed appetite suppressant before it was pulled for causing lung damage. Eighteen million Americans were on fen-phen before it was pulled from the market for causing severe damage to heart valves. Meridia was pulled for heart attacks and strokes, Acomplia was pulled for psychiatric side effects, including suicide, and the list goes on, as you can see below and at 2:51 in my video. 

    The fen-phen debacle resulted in “some of the largest litigation pay-outs ever seen in the pharmaceutical industry, with individual amounts of up to US$200,000 and a total value of ~US$14 billion,” but that’s all baked into the formula. If you read the journal PharmacoEconomics (and who doesn’t!), you may be aware that a new weight-loss drug may injure and kill so many that “expected litigation cost” could exceed $80 million, but Big Pharma consultants estimate that if it’s successful, the drug could bring in more than $100 million, so do the math. 

    What does work for weight loss? I dive deep into that and more in How Not to Diet.  For more of my videos on weight loss, check out the related videos below. 

    [ad_2]

    Michael Greger M.D. FACLM

    Source link

  • How Stress Affects Heart Health

    How Stress Affects Heart Health

    [ad_1]

    For many people, stress is part of everyday life. The demands of work, family, and other quotidian pressures can leave one feeling angry, agitated, anxious, downtrodden, or burned out.

    While these kinds of day-to-day challenges are often described as mild forms of stress, the reality is that some people will experience them more often and more significantly than others. And there’s mounting evidence linking these and other forms of stress to heart-related health problems.

    “We know from several studies in different populations that emotional and psychological stress is associated with an increased likelihood of developing and dying of cardiovascular disease,” says Dr. Beth Cohen, a stress researcher and professor of medicine at the University of California, San Francisco. 

    For example, research on stress in the workplace has found that people who are under regular strain or who work long hours are up to 40% more likely than their less-taxed counterparts to eventually develop heart disease or stroke. “There are also studies looking at what we call perceived stress, which is the amount of stress a person reports feeling, regardless of cause,” Cohen says. There again, research has found that people who report feeling a lot of stress are at elevated risk for cardiovascular problems down the road.  

    Meanwhile, some of Cohen’s work has examined the health effects of stress that stem from deeply traumatic experiences—such as those related to military combat service or interpersonal violence. She says post-traumatic stress disorder (PTSD) and other stress-related disorders are associated with increased cardiovascular disease risks. 

    But while stress appears to be a major risk factor for heart trouble, there’s a lot about the relationship between stress and heart health that experts are still sorting out. For example, how much stress is too much? “Not all challenging or stressful situations are unhealthy,” Cohen says. “Short-term stress in specific situations, such as working to overcome a difficulty, may actually be beneficial.” Another lingering question: Does stress itself damage the heart, or does stress lead to other things (smoking, poor sleep, an unhealthy diet) that cause the bulk of the harm? These are the types of questions that science has not fully answered.

    Untangling the exact relationship between stress and health problems—including heart disease, but also other stress-related conditions such as Type 2 diabetes—is now the goal of research teams across the world. They’ve made progress in showing how stress may change a person—both inside and out—in ways that could contribute to heart trouble.

    Read More: Feeling Off? It Could Be ‘Ambient’ Stress

    Defining stress

    In order to understand the negative effects of stress, medical researchers must first define what it means to be “stressed.” That’s easier said than done. 

    “There’s the lay-person idea of stress, but defining it more scientifically is challenging,” says Dr. Ian Kronish, an associate professor of medicine and associate director of the Center for Behavioral Cardiovascular Health at Columbia University in New York. 

    For example, some researchers have defined stress as “[a]ny physical or psychological stimuli that disrupt homeostasis.” By this broad definition, watching a suspenseful TV show or hurrying to an appointment are both forms of stress. Both are likely to raise a person’s heart rate and blood pressure in measurable ways. But most experts, like laypeople, recognize that these fleeting periods of stress probably aren’t the kinds that contribute to heart problems.

    Another definition of stress is one that encompasses experiences or events that lead to unhelpful changes within the body’s stress-response system. It’s these disruptive forms of stress, Kronish says, that may contribute to heart disease and other health issues. These forms of stress are often sorted into two types: acute stress and chronic stress. 

    Acute stressors are experiences that lead to very intense activation of the body’s fight-or-flight response. “These are events where the demands of the situation outstrip a person’s resources to handle them,” Kronish says. “Living through a major disaster, whether from natural causes or something like a terrorist event, could be the kind of acute stress that leads to disruptions within these internal systems.” Chronic stress, meanwhile, refers to stressful experiences that may not pose an immediate threat to someone’s health, but that happen regularly and persist for long periods of time. Working in a hectic and draining profession is one example of a chronic stressor that, over time, could lead to perturbations of the body’s stress-response system.

    While acute and chronic stress may seem like straightforward concepts, nailing down when and how they harm a person’s health is difficult. Different people will respond to the same stressful situation in different ways; not all veterans with combat experience develop PTSD, and not all people who work in demanding professions develop adverse health effects. There’s also evidence that other lifestyle or environmental factors—such as a person’s exercise habits, their diet, and their social relationships—can help determine whether stress leads to health problems. “When I try to draw this out for people, it ends up looking like a big spider web of connections,” Cohen says. “All of these other things that are important to a person’s psychological and cardiovascular health may affect how they’re impacted by stress.”

    It has also been a challenge for researchers to measure stress. “With stress, we don’t have something like blood pressure where I can sit you down and measure it and know exactly what it means,” Cohen says. Likewise, when someone with a history of stress develops heart trouble, there is currently no way for experts to determine whether stress caused that person’s health problems. “We don’t have a test that can tell whether your heart has been impacted negatively by stress,” Kronish says. 

    In an effort to address these and other gaps, researchers have focused much of their attention on mapping out the underlying connections between stress and health. That work has revealed how acute and chronic stress may contribute to heart trouble, diabetes, and other health problems. 

    The stress-heart connection

    The human body reacts to stress in predictable ways. Blood pressure and heart rate increase, while breathing becomes shallow and rapid. Muscles grow tense and blood sugar levels rise. Alertness and attention sharpen. This all happens because stress-related hormones are circulating throughout the brain and body, ramping up activity in the sympathetic nervous system (SNS) and preparing the entire organism to respond to any potential threats. While SNS activation is the kind of stress a person can feel, a lot more is going on inside them. In fact, stress affects the operation of every organ and system in the body, including the immune system. 

    All of this is normal and healthy. The body is made to manage stress, and, typically, it will recover from periods of stress without any lingering ill-effects. But in those situations when a stressful event is very severe, or when stress lingers for long periods of time, changes may occur that threaten the heart. “Increases in blood pressure, which can be initiated by stress, will increase pressure on the walls of blood vessels, and can therefore lead to cardiovascular damage,” says Dr. Amgad Makaryus, a cardiologist and professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health in New York. 

    The effect stress has on blood pressure is just one of many theorized ways that stress may lead to heart trouble. “With stress, it’s difficult to pinpoint the exact way it’s doing damage, but we know one of the end products of stress is inflammation,” Makaryus says. While stress usually leads to temporary increases in inflammatory activity, chronic stress can produce persistent low-grade inflammation. This sort of simmering, all-the-time inflammation has been tied to heart disease, but also to Type 2 diabetes, depression, and other illnesses of the mind and body.

    While there’s good evidence supporting the theory that too much stress damages the body via heightened inflammation and other forms of internal dysregulation, experts say there are still a lot of details to be worked out. “The field is still trying to untangle the various biological and behavioral pathways that may connect stress and cardiovascular health,” Kronish notes. His group has spent a lot of time looking at the ways stress changes a person’s behavior in ways that may lead to health problems. He says stress motivates some people to take better care of themselves, but it can also lead people to forgo exercise and social gatherings, to smoke or drink more than they otherwise would, and to adopt other habits that imperil their health. “Sleep is another pathway that might connect stress to poor cardiovascular outcomes,” he says. There’s evidence that stressed people tend to sleep poorly, and a persistent lack of sleep has been associated with a wide assortment of health problems. 

    Untangling all these different stress-related harms—both the biological and the behavioral—is no easy task. They’re likely all interconnected. “People talk a lot about a dysregulated stress system, but my sense is it’s a more complicated story,” Kronish says. “There are so many factors to tease apart.”

    Read More: How COVID-19 Changes the Heart—Even After the Virus Is Gone

    How to reduce your risks

    Stress appears to threaten the heart in numerous ways. Safeguarding the heart from that assault may require a multi-pronged defensive strategy, experts agree. “People hear that stress is bad for the heart, and so they should do things to reduce stress,” Kronish says. “But the truth is we don’t have a grand slam stress-reducing intervention that we know will protect the heart from stress in all people.”

    For example, psychotherapy has shown promise for the reduction of both stress and its attendant heart risks, and Cohen recommends it for people with PTSD and other stress-related mental health conditions, such as anxiety, depression, and trouble sleeping. But the evidence supporting its protective benefits for the heart is inconsistent. “Some trials have looked at psychotherapy and stress reduction techniques,” she says. “They’ve consistently led to better mental health outcomes, but they’ve had mixed evidence in terms of whether they reduce heart disease risk.”

    Meanwhile, Makaryus says medication-based treatments aren’t the answer—at least not yet. “Medications are a big part of cardiovascular disease treatment, but we don’t have an easy pill that will solve this,” he says of stress-related heart trouble. “I think the key is prevention.”

    It may not be surprising, but he and others say the time-tested elements of a healthy lifestyle—regular exercise, a proper diet, good sleep, and time spent with friends—can help a person recover from stress and reduce their risks for stress-related health problems. “Many people deal with stress by connecting with family and friends, or connecting with a spiritual group,” Cohen says. Leaning on other people for support—as opposed to isolating yourself and dealing with stress on your own—seems to be one of the best ways to reduce its harms, she says. 

    For many of us, stress is inescapable. But we all have the power to eat better, exercise, and engage in other healthy activities that appear to help limit the harms of stress. “There are mysteries left to unravel,” Cohen adds, “but we already know many ways how to preserve and protect cardiovascular health.” 

    [ad_2]

    Markham Heid

    Source link

  • What to Know About Hypertrophic Cardiomyopathy in Kids

    What to Know About Hypertrophic Cardiomyopathy in Kids

    [ad_1]

    The human heart is a muscle, but it’s also a kind of complicated balloon—a balloon that fills and empties roughly 60 to 100 times every minute, and several billion times during the course of a lifetime.

    Among people with hypertrophic cardiomyopathy, the walls of the heart muscle are abnormally thick. This thickness can interfere with the heart’s normal filling-and-emptying operation. “If you think of a balloon made with super-thick rubber, you have to blow harder to fill it, and it’s the same with a hypertrophic heart,” says Dr. Daphne Hsu, professor of pediatrics and medicine at Pediatric Heart Center of Montefiore/Einstein in New York. 

    Hypertrophic cardiomyopathy is the most common form of genetic heart disease in the U.S. and the second commonest heart-muscle disease among children. Roughly 1 out of 500 adults is thought to be living with it. It’s unclear exactly how many American kids have the condition, but experts estimate its prevalence somewhere in the neighborhood of three cases per 100,000 children. That makes it a very rare disease. However, despite its uncommonness, hypertrophic cardiomyopathy is one of the leading causes of sudden death in young athletes. While it’s true that the condition can in some cases be life-threatening, it can also be almost very mild. “A lot of patients do not have many symptoms and their quality of life is good,” Hsu says.

    Here, she and other heart experts explain the basics of hypertrophic cardiomyopathy in children—including the different forms of the condition, how it’s identified and treated, and how it affects a young person’s health as they mature into adulthood. 

    Types and causes 

    Hypertrophic cardiomyopathy, like most other diseases, can range from mild to severe. In some cases, the heart’s functioning is only minimally impaired—if it’s impaired at all. In other cases, however, the heart’s ability to function properly may be significantly disturbed or weakened.

    While all cases of hypertrophic cardiomyopathy involve abnormal thickening of the heart muscle, this thickening may or may not cause obstructions (blockages). In some cases, hypertrophic cardiomyopathy leads to heart rhythm problems (aka arrhythmias), and it can also disturb the way blood flows into and out of the heart’s chambers. Put another way, two children who both have hypertrophic cardiomyopathy may nonetheless have very different experiences and require very different types of treatment.

    The underlying causes of hypertrophic cardiomyopathy are similarly diverse. In most adults, and likewise in many children, the condition stems from genetic abnormalities. “There are many, many genetic mutations associated with hypertrophic cardiomyopathy,” Hsu says. (They number in the dozens.) While experts have identified a lot of the mutations that cause hypertrophic cardiomyopathy in adults, the condition is not as well-mapped in kids. “We’re learning more about [these mutations] and we’re working on better techniques to measure them, but right now we don’t know most of them,” she says. While these mutations may be inherited from one’s parents, that’s not necessarily the case. “Sometimes genetic mutations occur spontaneously,” Hsu says. “Often if we do testing, we don’t find the [hypertrophic cardiomyopathy] mutations in either of the parents.”

    Apart from mutations that specifically cause hypertrophic cardiomyopathy, the condition can also develop as a complication of a metabolic disorder. “Infants and very young children can have it because the heart muscle’s metabolism is not right, meaning there’s an accumulation of things like sugars that make the heart muscle thicker,” she explains. In these cases, hypertrophic cardiomyopathy is often just one aspect of a broader and systemic illness that affects the brain, the liver, and other organs. According to research in the journal Heart, these cases represent less than 10% of all childhood hypertrophic cardiomyopathies, and they’re almost always recognized at birth, as opposed to later on during childhood or adolescence.

    Read More: What to Know About Damar Hamlin’s Heart Event, Commotio Cordis

    Living with hypertrophic cardiomyopathy

    The main symptoms of hypertrophic cardiomyopathy are shortness of breath, fatigue, chest pain, heart palpitations (a fluttering feeling), and light-headedness (often just after standing or sitting up). These symptoms may be mild or unnoticeable. They may also be moderate or severe. “What life looks like depends on whether a child has signs of heart failure or arrhythmia, but heart failure is not very common,” Hsu says. In many cases, symptoms become more noticeable following physical activity; exercise causes the heart to beat faster and pump more blood, and this exertion can make hypertrophic cardiomyopathy worse. 

    While sudden cardiac death is possible, the risk of this happening varies from one child to the next. “The risk of cardiac death among all children with hypertrophic cardiomyopathy is approximately 1.5% per year, but some kids are at greater risk than others,” says Dr. Juan-Pablo Kaski, a pediatric cardiologist and director of the Centre for Paediatric Inherited and Rare Cardiovascular Disease at University College London. “There are clinical models we can use to estimate the risk for a particular child.” 

    Depending on that risk, some kids with the condition may be advised to avoid sports or strenuous exercise. But that’s not always the case. “Most children can do all the things their peers would do,” Kaski says. “The only difference is they need to come to a clinic every six months to a year for a checkup.” 

    There was a time when pretty much all children with hypertrophic cardiomyopathy were advised to avoid vigorous exercise, but the thinking on that has changed. “There’s been a trend to have more freedom for sports participation,” says Dr. Jeffrey Geske, a cardiologist and hypertrophic cardiomyopathy specialist at the Mayo Clinic in Minnesota. This shift has happened in part because experts have become more adept at identifying the people who are most at risk for sports-related complications or death. “We also know that sports and activities are good for people,” Geske adds. “So it’s about balancing the risks and the benefits.”

    Hsu echoes these sentiments. “It’s not healthy for a child’s body or mind to be restricted from normal activities and sports,” she says. “There are many kids with hypertrophic cardiomyopathy who play sports, but the decision to allow a child to play requires extensive discussion between the cardiologist and family.”

    It’s also worth noting that sudden cardiac death does not always occur as a result of exercise. “Most children who die don’t die during exercise,” Kaski says. “They die during normal day to day activities.” Again, while the risk of sudden death is elevated in kids with the condition, it is nonetheless uncommon.

    Read More: 7 Myths About Cholesterol, Debunked

    Diagnosis and treatment

    Hypertrophic cardiomyopathy is usually identified and diagnosed in one of three ways. “One is through family screening,” says University College London’s Kaski. In these situations, a child’s parent or relative is diagnosed with the condition, and follow-up screening reveals that the child also has it. “The second way is that a child has symptoms—so things like breathlessness during exercise, chest pain or palpitations, or near-fainting episodes—and that triggers a referral [to a heart specialist],” he says. “The third way is through incidental finding.” In these cases, health care providers spot the condition while performing routine medical exams, or while looking for something else. 

    Once the condition is diagnosed, Mayo’s Geske says that treatment is often dictated by a person’s symptoms. “If somebody has no symptoms, then often no treatment is needed beyond some lifestyle modifications,” he says. These lifestyle changes may or may not include avoiding heavy exercise. Kids (and adults) with the condition are also usually advised to drink plenty of water or fluids because dehydration can make symptoms worse, Geske says. A healthy diet and regular exercise are also recommended. 

    The symptoms of hypertrophic cardiomyopathy, whether mild or severe, tend to stem from two particular complications: heart arrhythmias and heart failure. Heart failure happens “when the heart can’t fill or pump out as well as it should, and the heart can’t supply the body with the blood it needs,” Hsu says. Heart arrhythmias happen when the hypertrophied muscle causes electricity to travel through the heart in an abnormal way, and as a result the heart may have unusual rhythms.”

    Doctors treat these complications with medications, surgical procedures, and/or implanted heart devices. “So if there’s heart failure, we have drugs that help the heart fill and empty better,” she says. These include beta blockers, calcium-channel blockers, and other drugs that are also used to treat heart failure in adults. Medications tend not to work well for heart rhythm problems, she says, and so these arrhythmias—if severe—may require surgical intervention or the implantation of a pacemaker. (Hsu says this isn’t as common in kids as it is in adults.) 

    Hypertrophic cardiomyopathy can also block the flow of blood through the heart. These blockages usually require surgical intervention. In rare cases, a heart transplant may be necessary. “The ultimate treatment is taking out the heart and giving a new one, and this works well—people do well after a transplant,” Hsu says. 

    Long-term outlook

    Experts say the long-term prognosis for a child with hypertrophic cardiomyopathy can be hard to pin down. Some go on to live long lives free of major symptoms. “The vast majority, I would say, have a good quality of life and good life expectancy,” Kaski says.  

    However, complications such as heart failure or arrhythmias, even if mild during childhood and adolescence, can grow worse during adulthood. “The progression [of heart complications] seems to be more quick when hypertrophic cardiomyopathy is diagnosed in childhood,” he says. “So the thickening of the heart muscle or abnormal heart rhythms—all that tends to happen more quickly.” 

    Hsu says that kids with the condition may be at greater lifelong risk for heart trouble, although she says this is more a matter of educated guesswork than established fact. “We don’t have a database going back 50 or 100 years, so we really don’t know a lot about long-term outcomes,” she says. “In general, we know if you have heart disease as a child, you usually have more severe disease as you get to 40 or 50 and beyond.” But every patient is unique. 

    Overall, experts say the situation for a majority of kids with hypertrophic cardiomyopathy is far from dire. In fact, a lot of kids who have it may never even know about it. “When a patient is first diagnosed, you go and Google this condition and a lot of scary stuff shows up,” Geske says. “But most people with this disease have a normal life span.”

    Experts are learning more and more about the condition every day. While prospects for most kids with hypertrophic cardiomyopathy are already good, they’re sure to improve as medical science’s understanding of this disease expands and deepens in the years to come. “We now have the ability to recognize people at high risk, and we have more effective interventions,” Geske says. Things are all moving in the right direction.  

    [ad_2]

    Markham Heid

    Source link

  • Despite Progress, Black Americans See Heart Health Disparities

    Despite Progress, Black Americans See Heart Health Disparities

    [ad_1]

    Feb. 22, 2023 – It was week 17 of what should have been a typical Monday Night Football showdown featuring the Buffalo Bills and the Cincinnati Bengals. But Bills safety Damar Hamlin’s tackle of Bengals receiver Tee Higgins may ultimately have been a game changer – not only for football, but for heart disease disparities in the U.S. as well.

    Hamlin, 24, who had sudden cardiac arrest after getting hit in the chest by Higgins’s right shoulder during the first quarter of the Jan. 2 matchup, was down for roughly 19 minutes while first responders did cardiopulmonary resuscitation (CPR) and used an automated external defibrillator (AED) to restart his heart. The incident – which has focused attention on a rare condition (commotio cordis) and the importance of public action – may also be a turning point for a community that has long been in the spotlight for having poor heart health: Black Americans.

    “Even though we’ve made tremendous progress in reducing the burden of heart attack and stroke, we need a different approach to get everyone’s attention,” says Clyde Yancy, MD, chief of cardiology and vice dean for diversity and inclusion at Northwestern Medicine in Chicago, and past president of the American Heart Association.

    “Case in point is the episode with Damar Hamlin; everybody in the country is now aware of the benefit of CPR,” he says. “We haven’t always been able to leverage a moment that gets the attention of the community in such a rapid and robust way.”

    This especially true of many Black Americans, for whom community support for health and wellbeing is common.   

    “That’s the beginning of change that can happen across the board,” Yancy says.

    Persisting Disparities, Social Ties

    Black adults continue to have the highest rates of hypertension (high blood pressure) and have related complications at an earlier age, according to the American Heart Association. 

    Increased rates of heart failure, stroke, and narrowed blood vessels that reduce blood flow to the limbs (peripheral artery disease) also disproportionately affect Black Americans, even though overall rates of coronary heart disease are not significantly different than those found in white peers. 

    Moreover, recent findings from the ongoing Multi-Ethnic Study of Atherosclerosis (hardening of the arteries) show that compared with white, Chinese, and Hispanic people, Black people had the highest rates of dying from all causes, and after adjusting for age and sex, a 72% higher risk of dying from heart disease vs. white peers.

    “Once we adjusted for social determinants of health, the differences between Blacks and whites for the likelihood to die nearly went away,” explains Wendy Post, , MD, a professor of cardiology at Johns Hopkins Medicine in Baltimore and lead author of the study. “Meaning that if we had the same environment, we probably would have similar mortality rates.”

    With regard to “environment,” Post is referring to the impact of non-medical factors on health outcomes, better known as social determinants of health. More and more, research is focusing on how these factors tend to sustain health inequities and worse cardiovascular outcomes in Black Americans. 

    “We’re beginning to understand that this significant increase in cardiovascular disease is due to significant differences in social determinants of health. This can include everything from access to routine health care, insurance coverage, medications and, also, food supply and access to healthy food,” says Roquell Wyche, MD, a Washington, DC-based cardiologist. 

    Wyche explains that social determinants of health can also “include housing, access to a healthy environment that facilitates exercise, where a person can feel safe in their environment, socioeconomic status, work and job security, and transportation. All of these have significant impacts on cardiovascular health, and African-Americans experience greater social disadvantages across all of these determinants.” 

    Currently, the World Health Organization estimates that social determinants of health are responsible for as much as 55% of health outcomes overall. 

    Quentin Youmans, MD, a cardiology fellow at Northwestern Medicine Bluhm Cardiovascular Institute in Chicago, echoes Wyche, pointing to rates of high blood pressure in the Black community as an example. 

    “When we think about the main primary contributor for poor health and cardiovascular health, we think about hypertension as being one of the primary causes in Black Americans. And it’s not just the prevalence of hypertension; we know that Black patients, even if they have a diagnosis, are less likely to have their blood pressures controlled,” he says.

    “This [hypertension] is a very insidious disease” that can be undiagnosed and may not cause symptoms until a patient goes to the doctor with either cardiovascular disease or a stroke. “And, so, because of these factors that contribute to not having access to care, patients may have hypertension for longer.”

    Importantly, access to care includes access to proven treatments. A National Institutes of Health-supported study published last month in Circulation: Heart Failure showed that Black patients treated at heart failure specialty centers were roughly half as likely to receive evidence-based, life-changing therapies (such as transplants or mechanical blood pumps known as ventricular assist devices, or VADs) as white adults.

    But when the researchers accounted for things that affect health outcomes, including disease severity and social determinants of health such as education, income, and insurance, disparities remained, even when patients expressed the same preference for lifesaving treatments. In their discussion, the study authors also suggested that unconscious bias and structural racism also contribute to how these health determinants play out across many conditions.

    “We need to look at and see how structural racism is really affecting African Americans, particularly in social determinants of health,” notes Wyche, who’s also leadership development chair for the American Heart Association’s Greater Washington Region Board of Directors. 

    Still, this is not to say that genetics are not important, but even a family tendency to have conditions linked to heart disease – such as type 2 diabetes – have direct ties to determinants of health. For example, poor access to healthy food or the ability to afford medicine can worsen diabetes or, more importantly, the ability to reverse prediabetes (the stage before diabetes) with lifestyle changes. Currently, the American Heart Association estimates that Black American men get diabetes 1.5 times more often than white men, and Black women 2.4 times more often than white women. 

    A Path Forward

    Structural racism and even unconscious bias play key roles in keeping up poor heart health outcomes in African Americans. Yancy emphasizes how the preponderance of heart disease is both a risk and an opportunity.

    “We know strategies that work; we have evidence that demonstrates that we can change the arc of this disease burden, and we can improve outcomes,” he says. “So, the greatest risk, the greatest need truly is in those who are self-described as African American or Black. But the greatest opportunity exists there as well if we deploy those things that we know to be true based on sound evidence.” 

    Yancy explains that in 2010, he helped lead American Heart Association efforts to drive change through the creation of “Life’s Simple 7” (updated in 2022 to Life’s Essential 8), which is a guidepost for achieving better heart health outcomes by changing certain behaviors and key measures of cardiovascular disease: diet, sleep, physical activity, smoking cessation, weight management, cholesterol, blood sugar, and blood pressure. 

    “Primordial prevention, which is prevention of risk itself, is a key consideration,” he says. “This really gets to the root cause of why we see hypertension and diabetes – so much of this is related to early childhood dietary decisions and physical activity.”

    Now, he says, “we just have to adopt the will to make changes at the community level.”

    One strategy, Wyche says, is to seek medical care in early adulthood, both to establish some sort of prevention strategy before disease develops, and to learn if risk factors such as high blood pressure or high cholesterol are already starting to drive full-blown conditions.

    “Just as annual routine medical care is key, we are noticing that particularly in African American women as early as their 20s, that they’re showing evidence of cardiovascular disease.” 

    Another strategy is to recognize that social determinants of health and related health outcomes are commonly found across generations and families, and to see it as an opportunity.

    “The main thing that comes to mind is engaging not just the patient, but recognizing that risk can sometimes be generational,” says Youmans. “If we can shift our focus [from] the individual patient and think about generations and entire families, then we might be able to encourage more people to follow the recommendations needed to achieve ideal or optimal health.”

    Yancy, Youmans, Post, and Wyche remain optimistic, even amid the disparities in health care access and outcomes – and increased public attention their link to oppressive structures and policies – that both COVID-related disruptions and Black Lives Matter, respectively, have brought to the fore. 

    “I believe that we’ve gone through a generational movement,” says Yancy. “I think that in 10 years, we’ll see the positive yield of transformational experiences in the last 3 years with a more diversified workforce, a workforce that is more aware of the disease burden in the community members, community members that recognize the maladies of their own social environment, and leaders seeking change vis-a-vis public policy for change.”

    [ad_2]

    Source link

  • Happy, Loved Teens Become Heart-Healthier as Adults

    Happy, Loved Teens Become Heart-Healthier as Adults

    [ad_1]

    By Amy Norton 

    HealthDay Reporter

    WEDNESDAY, Jan. 11, 2023 (HealthDay News) — When teenagers feel good about themselves and their lives, it may also do their hearts good in the long run, a new study suggests.

    Researchers found that teenagers who generally felt happy, optimistic and loved went on to show better cardiovascular health in their 20s and 30s, versus kids who lacked that level of mental well-being.

    Overall, they were more likely to maintain a healthy weight, as well as normal blood pressure, blood sugar and cholesterol levels. And having such positive feelings appeared particularly important for Black teenagers’ future health.

    The idea that kids’ well-being can affect their health well into adulthood is not new. Studies have shown that childhood obesity, for example, is tied to increased risks of various health conditions — including type 2 diabetes and heart disease — later in life.

    And the links go beyond physical factors: Adults who went through childhood hardships like abuse and neglect are at heightened risk of heart disease and other ills, as well.

    Experts said the new study asked a different question: Are there positive psychological “assets” that might help protect kids’ physical health in the long run?

    “One thing I’m struck by is, we really don’t have a handle on the ‘good things’ that kids need to support their cardiometabolic health,” said lead researcher Farah Qureshi, an assistant professor at the Johns Hopkins Bloomberg School of Public Health, in Baltimore.

    To dig into the question, her team examined data from a national health study that enrolled nearly 3,500 U.S. high school students in the 1990s and followed them for more than two decades.

    At the outset, the students answered questions that gauged five psychological assets: happiness; hopefulness about the future; high self-esteem; feeling socially accepted; feeling loved and wanted.

    The bad news: More than half of kids — 55% — had none or only one of those positive feelings.

    But when they had four or five of those assets, they were about 69% more likely to maintain good cardiovascular health into their 30s, compared with their peers. That was with a range of other factors — like family income, parents’ education and kids’ body weight — taken into account.

    What’s more, those positive feelings seemed especially critical for Black teens. When they did not have them, they were highly unlikely to be in good cardiovascular health 20 years later: Only 6% were.

    As for why, Qureshi said the way kids feel about themselves and their lives can affect their health behaviors.

    It’s generally tough to exercise and eat healthfully on a regular basis, she noted. But if you feel good about yourself and the future, that’s a good motivator.

    Adrienne Kovacs, a volunteer expert with the American Heart Association, agreed.

    “When we’re optimistic, for example, we expect that we’re going to be able to handle a situation, so we behave accordingly,” said Kovacs, a clinical and health psychologist with Equilibria Psychological Health in Toronto.

    That could be the difference between believing, or not believing, that you can change an unhealthy habit, Kovacs said.

    Beyond that, both experts said, psychological factors like chronic stress can have direct physiological effects on the body.

    Kovacs said the new study is a reminder that “we need to broaden our conceptualization of cardiovascular risk factors.” And that has to begin early in life, she noted.

    In line with past research, this study found that an unfortunately small number of participants maintained good cardiovascular health into their late 30s: just 12% overall.

    But having psychological assets in adolescence strengthened those odds. Meanwhile, a lack of those positive feelings seemed particularly detrimental to Black teens: In the study group with one or no psychological assets, only 6% of Black kids were in good cardiovascular health in adulthood, versus 12% of their white counterparts.

    That implies that supporting teenagers’ mental well-being is a matter of health equity, too, both experts said.

    Qureshi said that for Black teenagers, who face the chronic stress of structural racism, having a strong sense of self-esteem, belonging and feeling loved may be particularly critical.

    Parents can, of course, support those feelings, Qureshi and Kovacs said. But so can any adult in a child’s life, as well as schools, community programs and society at large. As an example, Kovacs pointed to the health care system, which could do a better job of “creating an environment where everyone feels they belong.”

    For families, Qureshi said, supporting kids’ mental well-being “can be as simple as sitting down together at dinner and asking them how they’re doing — those things we can take for granted.”

    The study was published online Jan. 11 in the Journal of the American Heart Association.

    More information

    The American Heart Association has advice on maintaining lifelong good health.

     

     

    SOURCES: Farah Qureshi, ScD, MHS, assistant professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.; Adrienne Kovacs, PhD, volunteer expert, American Heart Association, Dallas, and clinical and health psychologist, Equilibria Psychological Health, Toronto; Journal of the American Heart Association, Jan. 11, 2023, online

    [ad_2]

    Source link